Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             420 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 27 A DOSIMETRIC ANALYSIS OF RADIATION THERAPY ONCOLOGY GROUP (RTOG) 0321: THE IMPORTANCE OF URETHRAL DOSE Hsu, I.
 2012
 103 S2 p. S11-
1 p.
 artikel
2 61 AUSTRALIAN PROSTATE BRACHYTHERAPY Miller, J.
 2012
 103 S2 p. S24-
1 p.
 artikel
3 Author Index 2012
 103 S2 p. S168-S178
11 p.
 artikel
4 19 BRACHYTHERAPY CALIBRATION STANDARDS IN THE USA De Werd, L.
 2012
 103 S2 p. S8-
1 p.
 artikel
5 13 BRACHYTHERAPY IN CANCER: ART AND SCIENCE – ACCOMPLISHMENTS IN OVER A CENTURY Perez, C.
 2012
 103 S2 p. S5-S6
2 p.
 artikel
6 101 BRACHYTHERAPY: THE IAEA VISION AND POLICY. Fidarova, E.
 2012
 103 S2 p. S39-S40
2 p.
 artikel
7 21 CLINICAL RESULTS Pötter, R.
 2012
 103 S2 p. S8-S9
2 p.
 artikel
8 6 CONCLUSION – IMAGE-GUIDED BRACHYTHERAPY FUTURE AND EVALUATION Dimopoulos, J.
 2012
 103 S2 p. S2-S3
2 p.
 artikel
9 49 DIFFERENT MATHEMATICAL MODELS AND WHAT ÍS MISSING Bourel, V.
 2012
 103 S2 p. S20-
1 p.
 artikel
10 22 DVH PARAMETER ANALYSIS Tanderup, K.
 2012
 103 S2 p. S9-
1 p.
 artikel
11 Editorial Board 2012
 103 S2 p. iii-
1 p.
 artikel
12 10 ELIOT TRIALS IN MILAN: RESULTS Orecchia, R.
 2012
 103 S2 p. S4-
1 p.
 artikel
13 18 20 EURAMET PROJECT: NEW CALIBRATION STANDARDS IN BRACHY-THERAPY Sander, T.
 2012
 103 S2 p. S7-S8
2 p.
 artikel
14 62 EUROPE Lievens, Y.
 2012
 103 S2 p. S24-
1 p.
 artikel
15 7 EUROPEAN EXPERIENCE Polgár, C.
 2012
 103 S2 p. S3-
1 p.
 artikel
16 106 GLOBAL PERSPECTIVE ON GYNECOLOGIC BRACHYTHERAPY: CHALLENGES AND DEVELOPMENTS Viswanathan, A.
 2012
 103 S2 p. S41-
1 p.
 artikel
17 59 HOW CAN BRACHYTHERAPY BE MORE SYSTEMATICALLY USED IN EMERGING COUNTRIES Bilimagga, R.
 2012
 103 S2 p. S23-
1 p.
 artikel
18 129 IMPROVING INDIVIDUALIZED CANCER CARE WITH A NOMOGRAM FOLLOWING SURGERY Alektiar, K.
 2012
 103 S2 p. S52-
1 p.
 artikel
19 12 INTRODUCTION Haie-Meder, C.
 2012
 103 S2 p. S5-
1 p.
 artikel
20 1 INTRODUCTION Haie-Meder, C.
 2012
 103 S2 p. S1-
1 p.
 artikel
21 96 IS HIGH SAFETY IN BRACHYTHERAPY A RESULT OF ADVANCED TECHNIQUES AND ADVANCED IMAGING? Baltas, D.
 2012
 103 S2 p. S38-
1 p.
 artikel
22 117 IS THE FUTURE OF BRACHYTHERAPY MODEL-BASED? Papagiannis, P.
 2012
 103 S2 p. S47-
1 p.
 artikel
23 17 IS THERE A ROLE FOR FOCAL THERAPY IN PROSTATE CANCER – NON-RADIATION TECHNIQUES? de Reijke, T.
 2012
 103 S2 p. S7-
1 p.
 artikel
24 91 LONG TERM OUTCOMES AND RECURRENCE PATTERN FOLLOWING ACCELERATED PARTIAL BREAST IRRADIATION USING MAMMOSITE Ravi, A.
 2012
 103 S2 p. S37-
1 p.
 artikel
25 11 LONG TERM RESULTS AND ONGOING TRIALS OF PERMANENT BREAST SEED IMPLANT Pignol, J.
 2012
 103 S2 p. S4-S5
2 p.
 artikel
26 116 MODEL-BASED DOSE CALCULATION TECHNIQUES IN BRACHYTHERAPY Beaulieu, L.
 2012
 103 S2 p. S46-S47
2 p.
 artikel
27 5 MODERN BRACHYTHERAPY: ROLE OF ULTRASOUND Hoskin, P.
 2012
 103 S2 p. S2-
1 p.
 artikel
28 4 MRI: IMPACT ON BRACHYTHERAPY Jurgenliemk-Schulz, I.M.
 2012
 103 S2 p. S2-
1 p.
 artikel
29 107 MULTICENTER STUDIES WITH IMAGE GUIDED BRACHYTHERAPY IN CERVICAL CANCER Lindegaard, J.C.
 2012
 103 S2 p. S41-S42
2 p.
 artikel
30 60 NORTH AMERICA Beyer, D.
 2012
 103 S2 p. S23-
1 p.
 artikel
31 8 NORTH AMERICAN EXPERIENCE Arthur, D.W.
 2012
 103 S2 p. S3-S4
2 p.
 artikel
32 OC-67 AAPM PRACTICE GUIDELINES FOR COMS EYE PLAQUE BRACHYTHERAPY Chiu-Tsao, S.T.
 2012
 103 S2 p. S26-
1 p.
 artikel
33 OC-32 A DOSIMETRIC ANALYSIS OF PROSTATE CANCER TREATMENT: CAN SBRT REALLY ACHIEVE WHAT HDR BRACHYTHERAPY CAN? Spratt, D.E.
 2012
 103 S2 p. S13-
1 p.
 artikel
34 OC-139 A FAST AND ACCURATE GPU-BASED PRIMARY+SCATTER ALGORITHM FOR LDR-BRACHYTHERAPY Bourque, A.
 2012
 103 S2 p. S56-S57
2 p.
 artikel
35 OC-81 A MULTICENTRE COMPARISON OF INTER- AND INTRA-FRACTIONAL ORGAN MOVEMENT IN CERVIX CANCER BT AND ITS DOSIMETRIC IMPACT Nesvacil, N.
 2012
 103 S2 p. S33-
1 p.
 artikel
36 OC-84 A NOVEL METHOD TO ASSESS ORGAN MOTION DURING 3D IMAGE-GUIDED PULSED DOSE RATE CERVIX CANCER BRACHYTHERAPY Champoudry, J.
 2012
 103 S2 p. S34-
1 p.
 artikel
37 OC-34 A NOVEL METHOD TO QUANTIFY PROSTATE SEED IMPLANT PLAN QUALITY BY PERFORMING INDIVIDUAL SEED DISPLACEMENT ANALYSIS Le, Y.
 2012
 103 S2 p. S14-
1 p.
 artikel
38 OC-70 A REVOLUTIONARY MULTI-POINT PLASTIC SCINTILLATION DETECTOR FOR IN VIVO DOSIMETRY IN HDR BRACHYTHERAPY Therriault-Proulx, F.
 2012
 103 S2 p. S28-
1 p.
 artikel
39 OC-38 BIOCHEMICAL DISEASE FREE SURVIVAL OF 3D IMAGE GUIDED BRACHYTHERAPY BOOST WITHIN A PERMANENT SEED IMPLANT Martin, A.G.
 2012
 103 S2 p. S16-
1 p.
 artikel
40 OC-56 BLADDER SPARING APPROACH WITH BRACHYTHERAPY IN 1040 PATIENTS Pieters, B.
 2012
 103 S2 p. S22-
1 p.
 artikel
41 OC-131 BREAST CANCER: EXTERNAL BEAM RADIOTHERAPY AND INTERSTITIAL BOOST APPLICATION – AN ANALYSIS OF 1065 PATIENTS. Hammer, J.
 2012
 103 S2 p. S53-
1 p.
 artikel
42 OC-87 BREAST-CONSERVING THERAPY WITH PARTIAL OR WHOLE BREAST RT: 10-YEAR RESULTS OF THE BUDAPEST RANDOMIZED TRIAL Polgár, C.
 2012
 103 S2 p. S35-
1 p.
 artikel
43 OC-69 BRINGING IN-VIVO FIBER-COUPLED BRACHYTHERAPY DOSIMETRY TO THE PATIENT Kertzscher, G.
 2012
 103 S2 p. S27-
1 p.
 artikel
44 OC-35 CBCT GUIDED INTRAOPERATIVE DYNAMIC DOSIMETRY SIGNIFICANTLY IMPROVES DOSIMETRY FOR I125 PROSTATE BRACHYTHERAPY Westendorp, R.
 2012
 103 S2 p. S14-S15
2 p.
 artikel
45 OC-78 CHARACTERIZATION OF A NEW CE3+ DOPED SCINTILLATION DETECTOR FOR IN VIVO DOSIMETRY IN HIGH DOSE RATE BRACHYTHERAPY Borroni, M.
 2012
 103 S2 p. S31-
1 p.
 artikel
46 OC-47 CLINICAL OUTCOMES FOLLOWING 3D IMAGE-GUIDED BRACHYTHERAPY FOR RECURRENT ENDOMETRIAL CANCER Lee, L.
 2012
 103 S2 p. S20-
1 p.
 artikel
47 OC-33 COMPARATIVE COST-EFFECTIVENESS OF SALVAGE BRACHYTHERAPY VS. HORMONAL TREATMENT OF RECURRENT PROSTATE CANCER Steuten, L.
 2012
 103 S2 p. S13-S14
2 p.
 artikel
48 OC-143 COMPARISON OF DIFFERENT FRACTIONATION SCHEDULES IN HDR BRACHYTHERAPY AS MONOTHERAPY FOR LOW-RISK PROSTATE CANCER Mavroidis, P.
 2012
 103 S2 p. S58-S59
2 p.
 artikel
49 OC-134 COMPARISON OF DOSE GRADIENT WITHIN THE PTVEVAL AS A FUNCTION OF OPTIMIZATION METHOD AND APPLICATOR USED IN APBI Marshall, I.R.
 2012
 103 S2 p. S54-
1 p.
 artikel
50 OC-115 CRITICAL ANALYSIS OF FMEA IMPLEMENTATION FOR BRACHY-THERAPY AT TWO INSTITUTIONS Scanderbeg, D.
 2012
 103 S2 p. S46-
1 p.
 artikel
51 OC-75 CT-GUIDED INTERSTITIAL IODINE-125 SEED IMPLANTATION IN THE TREATMENT OF SPINAL AND PARASPINAL MALIGNANCIES Liu, C.
 2012
 103 S2 p. S30-
1 p.
 artikel
52 OC-85 DEFORMATION ANALYSIS OF PDR BRACHYTHERAPY IN CERVICAL CARCINOMA Cuartero, J.
 2012
 103 S2 p. S34-S35
2 p.
 artikel
53 OC-65 DEVELOPMENT OF A WATER CALORIMETER AS A PRIMARY STANDARD FOR ABSORBED DOSE TO WATER FOR HDR BRACHYTHERAPY SOURCES de Prez, L.A.
 2012
 103 S2 p. S25-
1 p.
 artikel
54 OC-112 DOES INTER-FRACTION CATHETER MOTION AFFECT HR-CTV COVERAGE IN GYNECOLOGIC INTERSTITIAL BRACHYTHERAPY? Damato, A.
 2012
 103 S2 p. S44-
1 p.
 artikel
55 OC-135 DOES ONCOPLASTIC BREAST CONSERVING SURGERY CONTRAINDICATE PARTIAL BREAST MULTICATHETER BRACHYTHERAPY (APBI)? Roth, A.
 2012
 103 S2 p. S54-S55
2 p.
 artikel
56 OC-74 DOES PARTIAL BREAST BRACHYTHERAPY DECREASES SCATTERED FETAL DOSE IN PREGNANT WOMEN? Youssef, A.
 2012
 103 S2 p. S29-S30
2 p.
 artikel
57 OC-144 DOSIMETRIC AND RADIOBIOLOGICAL EVALUATION OF MANUALLY AND INVERSELY OPTIMIZED BRACHYTHERAPY TREATMENT PLANNING Palmqvist, T.
 2012
 103 S2 p. S59-S60
2 p.
 artikel
58 OC-68 DOSIMETRIC CHARACTERIZATION OF SURFACE APPLICATORS USED WITH BRACHYTHERAPY SOURCES Fulkerson, R.
 2012
 103 S2 p. S26-S27
2 p.
 artikel
59 OC-142 DOSIMETRY FOR HDR HEAD AND NECK BRACHYTHERAPY PATIENTS USING A GRID-BASED BOLTZMANN SOLVER Siebert, F.
 2012
 103 S2 p. S58-
1 p.
 artikel
60 OC-113 DYNAMIC MODULATED BRACHYTHERAPY (DMBT): CONCEPT, DESIGN, AND SIMULATIONS Song, W.
 2012
 103 S2 p. S44-S45
2 p.
 artikel
61 OC-90 EFFICACY OF YOUNG PATIENTS TREATED WITH ACCELERATED PARTIAL BREAST IRRADIATION FOR EARLY-STAGE BREAST CANCER Chen, P.Y.
 2012
 103 S2 p. S36-S37
2 p.
 artikel
62 OC-132 EXCELLENT COSMESIS AFTER APBI: DOES DOSE TO THE DERMAL VOLUME PROVIDE A BETTER PREDICTIVE CONSTRAINT THAN SKIN DMAX? Vera, R.
 2012
 103 S2 p. S53-S54
2 p.
 artikel
63 OC-45 FEASIBILITY OF ADC MAPPING IN ASSESSMENT OF TUMOR RESPONSE IN MRI-BASED HDR BRACHYTHERAPY FOR CERVICAL CANCER Hosseinzadeh, K.
 2012
 103 S2 p. S19-
1 p.
 artikel
64 OC-77 FEASIBILITY OF CONVEX OPTIMISATION WITH RADIOBIOLOGICAL MODELS FOR PROSTATE HDR-BRACHYTHERAPY Steenbergen, F.
 2012
 103 S2 p. S30-S31
2 p.
 artikel
65 OC-88 FIRST CLINICAL RESULTS OF THE GEC-ESTRO BREAST WG PHASE III MULTICENTRIC APBI TRIAL. Strnad, V.
 2012
 103 S2 p. S35-S36
2 p.
 artikel
66 OC-53 FROM LOW DOSE RATE TO HIGH DOSE RATE BRACHYTHERAPY IN LIP CARCINOMA: SAME RESULTS BUT LESS COMPLICATIONS Guinot, J.L.
 2012
 103 S2 p. S21-
1 p.
 artikel
67 OC-110 FUNCTIONAL MRI GUIDED HDR PROSTATE BRACHYTHERAPY TUMOUR BOOST: A FEASIBILITY STUDY Mason, J.
 2012
 103 S2 p. S43-
1 p.
 artikel
68 OC-28 HDR PROSTATE BRACHYTHERAPY IN ANATOMICALLY UNSUITABLE CASES (<20CC, >50CC, PRIOR TURP)-UNCOMPROMISED RESULTS Peddada, A.
 2012
 103 S2 p. S11-S12
2 p.
 artikel
69 OC-25 HIGH-DOSE RATE AFTERLOADING BRACHYTHERAPY USING ONE OR TWO FRACTIONS FOR LOCALISED PROSTATE CANCER Hoskin, P.
 2012
 103 S2 p. S10-S11
2 p.
 artikel
70 OC-46 HIGH DOSE RATE (HDR) INTRAOPERATIVE BRACHYTHERAPY IN THE MANAGEMENT OF RECURRENT GYNECOLOGIC MALIGNANCIES Scala, L.M.
 2012
 103 S2 p. S19-S20
2 p.
 artikel
71 OC-40 IMAGE GUIDED BRACHYTHERAPY ENDS THE DEBATE OF SYSTEMATIC RADICAL HYSTERECTOMY IN LOCALLY ADVANCED CERVICAL CANCER Mazeron, R.
 2012
 103 S2 p. S17-
1 p.
 artikel
72 OC-92 IMPACT OF MARGIN STATUS AFTER APBI: AN ANALYSIS OF THE AMERICAN SOCIETY OF BREAST SURGEONS MAMMOSITEEE REGISTRY TRIAL Wilkinson, J.B.
 2012
 103 S2 p. S37-
1 p.
 artikel
73 OC-111 IMPROVED APPLICATOR VISUALISATION FOR MR-GUIDED BRACHYTHERAPY OF CERVIX Liney, G.P.
 2012
 103 S2 p. S43-S44
2 p.
 artikel
74 OC-140 INFLUENCE OF HIGH ATOMIC NUMBER ELEMENTS IN HUMAN TISSUE IN DOSIMETRY FOR LOW ENERGY PHOTON BRACHYTHERAPY White, S.A.
 2012
 103 S2 p. S57-
1 p.
 artikel
75 OC-86 INTER-FRACTION UNCERTAINTIES OF OARS METRICS IN MULTI-FRACTION GYNECOLOGIC INTERSTITIAL BRACHY-THERAPY Bhagwat, M.
 2012
 103 S2 p. S35-
1 p.
 artikel
76 OC-42 INTERSTITIAL BRACHYTHERAPY VERSUS IMRT IN PATIENTS WITH CARCINOMA CERVIX UNSUITABLE FOR ICRT Gandhi, A.K.
 2012
 103 S2 p. S18-
1 p.
 artikel
77 OC-54 LONG TERM OUTCOMES OF INTERSTITIAL BRACHYTHERAPY IN SOFT TISSUE SARCOMAS Laskar, S.
 2012
 103 S2 p. S21-S22
2 p.
 artikel
78 OC-55 LONG-TERM RESULTS OF PDR BRACHYTHERAPY AS A BOOST IN SQUAMOUS CELL CANCERS OF THE ANAL CANAL Peiffert, D.P.
 2012
 103 S2 p. S22-
1 p.
 artikel
79 OC-44 MODELS FOR BRACHYTHERAPY DOSE DE-ESCALATION IN LOW RISK LOCALLY ADVANCED CERVICAL CANCER PATIENTS Mohamed, S.
 2012
 103 S2 p. S19-
1 p.
 artikel
80 OC-51 OUTCOME AND TOXICITY PROFILE AFTER BRACHYTHERAPY FOR SQUAMOUS CELL CARCINOMA OF THE NASAL VESTIBULE. Lipman, D.
 2012
 103 S2 p. S21-
1 p.
 artikel
81 OC-39 OUTCOME OF IMAGE GUIDED ADAPTIVE BRACHYTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER Lindegaard, J.C.
 2012
 103 S2 p. S16-S17
2 p.
 artikel
82 OC-89 PARTIAL BREAST ACCELERATED RADIOTHERAPY WITH MULTICATHETER HDR BRACHYTHERAPY Monti, C.
 2012
 103 S2 p. S36-
1 p.
 artikel
83 OC-133 PERIOPERATIVE HIGH DOSE RATE INTERSTITIAL BRACHYTHERAPY BOOST FOR PATIENTS WITH EARLY BREAST CANCER Sharma, D.N.
 2012
 103 S2 p. S54-
1 p.
 artikel
84 OC-52 PERIOPERATIVE VS. POSTOPERATIVE HIGH-DOSE-RATE BRACHYTHERAPY IN SQUAMOUS CELL HNC: A MATCHED-PAIR ANALYSIS Rodriguez-Ruiz, M.
 2012
 103 S2 p. S21-
1 p.
 artikel
85 OC-76 POSTOPERATIVE RADIATION THERAPY IN CARCINOMA OF ORAL TONGUE WITH HIGH DOSE RATE BRACHYTHERAPY BOOST – OUR EXPERIENCE Anand, V.
 2012
 103 S2 p. S30-
1 p.
 artikel
86 OC-82 PREPLANNING IMPROVES FEASIBILITY OF INTRACAVITARY/INTERSTITIEL BRACHYTHERAPY IN CERVICAL CANCER. Fokdal, L.
 2012
 103 S2 p. S33-S34
2 p.
 artikel
87 OC-26 PROSTATE CANCER: SINGLE FRACTION HDR BOOST – 12.5GY OR 15GY -WITH EXTERNAL BEAM RADIATION. A COMPARISON OF TOXICITY Arthur, C.
 2012
 103 S2 p. S11-
1 p.
 artikel
88 OC-41 PULSED LOW-DOSE RATE BRACHYTHERAPY FOR UTERINE CERVIX CARCINOMA: EXPERIENCE WITH 245 PATIENTS AT A SINGLE INSTITUTE Petit, A.
 2012
 103 S2 p. S17-
1 p.
 artikel
89 OC-66 QC OF LOW-ENERGY PHOTON BT SOURCES: RECOMMENDATIONS OF THE NETHERLANDS COMMISSION ON RADIATION DOSIMETRY (NCS) Rijnders, A.
 2012
 103 S2 p. S25-S26
2 p.
 artikel
90 OC-141 QUANTIFYING THE INTER-SOURCE ATTENUATION IN A DUAL-SOURCE HDR/PDR AFTERLOADER TREATMENT UNIT Plamondon, M.
 2012
 103 S2 p. S58-
1 p.
 artikel
91 OC-30 RESULTS OF I-125 STRANDS +- EBRT +-ADT IN LOCALIZED PROSTATE CANCER COMPARED TO KATTAN (2002) NOMOGRAM PREDICTIONS Zimmermann, J.
 2012
 103 S2 p. S13-
1 p.
 artikel
92 OC-114 ROBOT-GUIDED DELIVERY OF BRACHYTHERAPY NEEDLES ALONG NON-PARALLEL PATHS TO AVOID PENILE BULB PUNCTURE Cunha, J.A.M.
 2012
 103 S2 p. S45-S46
2 p.
 artikel
93 OC-29 SALVAGE HDR BRACHYTHERAPY FOR RECURRENT PROSTATE CANCER AFTER PRIOR DEFINITIVE RADIOTHERAPY: FIVE YEAR OUTCOMES Chen, C.P.
 2012
 103 S2 p. S12-
1 p.
 artikel
94 OC-72 SALVAGE HIGH DOSE RATE (HDR) INTERSTITIAL GYNECOLOGICAL BRACHYTHERAPY Patil, N.
 2012
 103 S2 p. S28-S29
2 p.
 artikel
95 OC-71 SINGLE NUCLEOTIDE POLYMORPHISMS (SNP'S) ASSOCIATED WITH LATE RADIATION TOXICITY AFTER PROSTATE BRACHYTHERAPY Leong, N.
 2012
 103 S2 p. S28-
1 p.
 artikel
96 OC-83 SPATIAL DOSIMETRIC SENSITIVITY ANALYSIS OF CONTOURING UNCERTAINTIES IN GYN 3D-BASED BRACHYTHERAPY Hellebust, T.P.
 2012
 103 S2 p. S34-
1 p.
 artikel
97 OC-24 TEN-YEAR OUTCOMES FOR PATIENTS WITH GLEASON 8-10 TREATED WITH HIGH DOSE RATE BRACHYTHERAPY BOOST Martinez, A.
 2012
 103 S2 p. S10-
1 p.
 artikel
98 OC-37 THE PROSTATE TUMORLET PROJECT. CRITICAL ANALYSIS OF D90: TILTING AT WINDMILLS? Todor, D.
 2012
 103 S2 p. S15-S16
2 p.
 artikel
99 OC-43 TREATMENT DOSE AND VOLUME PARAMETERS FROM 3 YEARS EXPERIENCE OF THE EMBRACE STUDY Nkiwane, K.
 2012
 103 S2 p. S18-
1 p.
 artikel
100 OC-136 UPDATE OF MULTI-CENTER CLINICAL DATA WITH NON-INVASIVE IMAGE-GUIDED BREAST BRACHYTHERAPY FOR TUMOR BED BOOST Hamid, S.
 2012
 103 S2 p. S55-
1 p.
 artikel
101 OC-73 URETHRAL DOSIMETRY AND TOXICITY WITH HIGH DOSE-RATE INTERSTITIAL BRACHYTHERAPY Rajagopalan, M.S.
 2012
 103 S2 p. S29-
1 p.
 artikel
102 OC-36 VALIDATION STUDY OF US-BASED HDR PROSTATE BRACHYTHERAPY PLANNING COMPARED TO CT GOLD STANDARD Gaztanaga, M.
 2012
 103 S2 p. S15-
1 p.
 artikel
103 146 ONE HUNDRED YEARS OF PROSTATE BRACHYTHERAPY Aronowitz, J.N.
 2012
 103 S2 p. S60-
1 p.
 artikel
104 58 PARTIAL BREAST IRRADIATION: FROM THE EUROPEAN SIDE Van Limbergen, E.
 2012
 103 S2 p. S23-
1 p.
 artikel
105 57 PARTIAL BREAST IRRADIATION: FROM THE US SIDE Kuske, R.
 2012
 103 S2 p. S23-
1 p.
 artikel
106 PD-124 CAN PTV_EVAL BE USED AS SURROGATE FOR NORMAL BREAST TISSUE IN THE DETERMINATION OF V150 AND V200? Bloom, E.
 2012
 103 S2 p. S50-
1 p.
 artikel
107 PD-121 COMPREHENSIVE DOSIMETRIC EVALUATION OF A SMALL STRUT-BASED APBI DEVICE: A RETROSPECTIVE SINGLE-INSTITUTION STUDY Morcovescu, S.
 2012
 103 S2 p. S49-
1 p.
 artikel
108 PD-123 DECLINE IN ACUTE URINARY TOXICITY: A LONG TERM STUDY IN 2011 PATIENTS WITH PROSTATE BRACHYTHERAPY Chan, E.K.
 2012
 103 S2 p. S50-
1 p.
 artikel
109 PD-128 DOSE CONTRIBUTION TO INVOLVED PELVIC NODES WITH 3D BRACHYTHERAPY FOR CERVIX CANCER; COMPARISON OF TWO CANCER CENTERS van den Bos, W.
 2012
 103 S2 p. S52-
1 p.
 artikel
110 PD-120 FIDUCIAL MARKERS IN COMBINED EBRT-LDR THERAPY OF PROSTATE CANCER: INFLUENCE ON LDR DOSE Landry, G.
 2012
 103 S2 p. S48-S49
2 p.
 artikel
111 PD-125 IRRADIATION OF LOCALIZED SQUAMOUS CELL CARCINOMA OF THE NASAL VESTIBULE Vanneste, B.G.L.
 2012
 103 S2 p. S51-
1 p.
 artikel
112 PD-126 POTENTIAL BENEFIT OF MRI-GUIDED BRACHYTHERAPY FOR ESOPHAGEAL CANCER Lips, I.M.
 2012
 103 S2 p. S51-
1 p.
 artikel
113 PD-119 REAL-TIME SOURCE POSITION VERIFICATION FOR MR-GUIDED SINGLE FRACTION HDR PROSTATE BRACHYTHERAPY. Moerland, M.A.
 2012
 103 S2 p. S48-
1 p.
 artikel
114 PD-122 STATIN USE NOT ASSOCIATED WITH IMPROVED OUTCOMES IN PATIENTS TREATED WITH BRACHYTHERAPY FOR PROSTATE CANCER Cuaron, J.
 2012
 103 S2 p. S49-S50
2 p.
 artikel
115 PD-127 VAGINAL BRACHYTHERAPY FOR INTERMEDIATE RISK ENDOMETRIAL CARCINOMA FROM SINGLE INSTITUTION Jhingran, A.
 2012
 103 S2 p. S52-
1 p.
 artikel
116 79 PERMANENT PERINEAL IMPLANT (PPI) SALVAGE OF PPI FAILURES: IS LESS MORE IN HIGHLY SELECTED PATIENTS Roach, M.
 2012
 103 S2 p. S31-S32
2 p.
 artikel
117 3 PET IMAGING IN BRACHYTHERAPY Lowe, V.
 2012
 103 S2 p. S1-S2
2 p.
 artikel
118 104 PHYSICS REQUIREMENTS FOR SKIN BRACHYTHERAPY Perez-Calatayud, J.
 2012
 103 S2 p. S41-
1 p.
 artikel
119 PO-414 A CASE-CONTROL STUDY OF PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA TREATED WITH PDR BRACHYTHERAPY Haddad, A.
 2012
 103 S2 p. S165-
1 p.
 artikel
120 PO-322 ACCELERATED PARTIAL BREAST IRRADIATION WITH HYBRID BRACHYTHERAPY APPLICATORS: FAVORABLE OUTCOMES AT FOUR YEARS Yashar, C.
 2012
 103 S2 p. S128-
1 p.
 artikel
121 PO-360 ACTIVITY CONTROL OF I-125 SEEDS FOR PROSTATE BRACHYTHERAPY Figueira, A.
 2012
 103 S2 p. S145-
1 p.
 artikel
122 PO-229 ACUTE AND CHRONIC TOXICITY ASSOCIATED WITH THREE HIGH-DOSE-RATE BRACHYTHERAPY MONOTHERAPY SCHEDULES Dilworth, J.
 2012
 103 S2 p. S92-
1 p.
 artikel
123 PO-206 ACUTE TOXICITY OF SINGLE FRACTION BOOST WITH HDR BT AFTER HYPOFRACTIONATED EBRT FOR LOCALLY ADVANCED PROSTATE CANCER Murata, K.
 2012
 103 S2 p. S83-
1 p.
 artikel
124 PO-252 ADJUVANT CARBOPLATIN/PACLITAXEL AND INTRAVAGINAL RADIATION FOR STAGE I-II SEROUS ENDOMETRIAL CANCER Kiess, A.
 2012
 103 S2 p. S101-S102
2 p.
 artikel
125 PO-416 ADJUVANT INTERSTITIAL BRACHYTHERAPY AFTER SALVAGE NECK DISSECTIONS Miccichè, F.
 2012
 103 S2 p. S165-S166
2 p.
 artikel
126 PO-244 A DOSIMETRY PHANTOM FOR GYNEOCOLOGICAL BRACHYTHERAPY Nazarnejad, M.
 2012
 103 S2 p. S98-S99
2 p.
 artikel
127 PO-222 A NEW DIMENSION TO THE TREATMENT OF LOCALIZED PROSTATE CANCER: 4D BRACHYTHERAPY Langley, S.
 2012
 103 S2 p. S89-
1 p.
 artikel
128 PO-303 ANISOTROPIC DOSE MODEL OF INTRACAVITARY VAGINAL BRACHYTHERAPY USING MULTI-RING INFLATABLE APPLICATOR Kuo, H.
 2012
 103 S2 p. S121-
1 p.
 artikel
129 PO-288 A NOVEL COMPUTER PROGRAM TO SUPPORT MR-GUIDED GYNECOLOGIC BRACHYTHERAPY Egger, J.
 2012
 103 S2 p. S115-
1 p.
 artikel
130 PO-189 A NOVEL IMAGE-FUSION TECHNIQUE BETWEEN CT AND T2-WEIGHTED MR IMAGES FOR POSTIMPLANT DOSIMETRY AFTER BRACHYTHERAPY Kunogi, H.
 2012
 103 S2 p. S77-
1 p.
 artikel
131 PO-417 A PHASE I FEASIBILITY STUDY FOR HDR INTERSTITIAL BRACHYTHERAPY USING 60CO FOR DIFFERENT SITES Basu, S.
 2012
 103 S2 p. S166-
1 p.
 artikel
132 PO-217 A RANDOMIZED TRIAL COMPARING SEED LOSS AND DISPLACEMENT OF ANCHORSEEDSEE TO STANDARD UNCOATED LOOSE SEEDS Batchelar, D.
 2012
 103 S2 p. S87-S88
2 p.
 artikel
133 PO-347 ARE TISSUE AND APPLICATOR HETEROGENEITIES EFFECT IMPORTANT IN BRACHYTHERAPY TPS? A REAL CASE Pereira, A.
 2012
 103 S2 p. S139-S140
2 p.
 artikel
134 PO-232 ARE URETHRAL TOXICITIES CORRELATED WITH DOSE AFTER INTERSTITIAL HDR BOOST BRACHYTHERAPY FOR PROSTATE CANCER? Broksch, R.
 2012
 103 S2 p. S94-
1 p.
 artikel
135 PO-286 ASSESSMENT OF “OLD FASHION” GYNAECOLOGIC HIGH-DOSE-RATE BRACHYTHERAPY – STARTING POINT TO MODERN BT TECHNIQUES Vasconcelos, A.
 2012
 103 S2 p. S114-
1 p.
 artikel
136 PO-195 BIOCHEMICAL RESULTS FOR HIGH RISK PROSTATE CANCER AFTER HIGH-DOSE-RATE BRACHYTHERAPY WITH EXTERNAL RADIOTHERAPY Arrojo Alvarez, E.
 2012
 103 S2 p. S78-S79
2 p.
 artikel
137 PO-277 BLADDER FILLING EFFECTS ON OAR IN IMAGE-GUIDED PLANNING OF INTRACAVITARY BRACHYTHERAPY FOR UTERINE CERVICAL CANCER Noda, S.
 2012
 103 S2 p. S111-
1 p.
 artikel
138 PO-336 BRACHYTHERAPY ACTIVITIES IN THE FRAMEWORK OF THE EUROPEAN METROLOGY RESEARCH PROGRAMME Schneider, T.
 2012
 103 S2 p. S135-
1 p.
 artikel
139 PO-278 BRACHYTHERAPY AS ORGAN PRESERVATION TREATMENT MODALITY FOR LOCALIZED / LOCALLY ADVANCED VULVAL CANCERS Mahantshetty, U.
 2012
 103 S2 p. S111-S112
2 p.
 artikel
140 PO-355 BRACHYTHERAPY DATASET QUALITY ASSURANCE USING THE GAMMA-INDEX METHOD Yang, Y.
 2012
 103 S2 p. S143-
1 p.
 artikel
141 PO-294 BRACHYTHERAPY EXPERIENCE IN GYNAECOLOGICAL TUMORS IN TURKEY Aslay, I.
 2012
 103 S2 p. S117-S118
2 p.
 artikel
142 PO-187 BRACHYTHERAPY FOR PROSTATE CANCER: EXPERIENCE IN LDR AND HDR IRRADIATION Albitskiy, I.
 2012
 103 S2 p. S76-
1 p.
 artikel
143 PO-169 BRACHYTHERAPY FOR YOUNG PROSTATE CANCER PATIENTS. WHAT IS DIFFERENT FROM ELDER PATIENTS? Yagi, Y.
 2012
 103 S2 p. S69-S70
2 p.
 artikel
144 PO-363 BRACHYTHERAPY IN THE HEAD AND NECK REGION USING INDIVIDUAL APPLICATORS – A TECHNICAL NOTE Niewald, M.
 2012
 103 S2 p. S146-S147
2 p.
 artikel
145 PO-412 BRACHYTHERAPY OF THE ORBIT IN YOUNG CHILDREN Sauerwein, W.
 2012
 103 S2 p. S164-
1 p.
 artikel
146 PO-358 BRACHYTHERAPY RADIOLUMINESCENT FIBER SENSOR: SEARCH FOR INFRARED RADIOLUMINESCENT MATERIALS Chiquita, S.
 2012
 103 S2 p. S144-
1 p.
 artikel
147 PO-411 BRACHYTHERAPY WITH IODINE 125 OR RUTHENIUM 106 FOR TREATMENT OF CHOROIDAL MELANOMAS MEASURING 5-7 MM IN THICKNESS Tagliaferri, L.
 2012
 103 S2 p. S163-S164
2 p.
 artikel
148 PO-315 CAN WE IMPROVE THE DOSE DISTRIBUTION FOR SINGLE OR MULTI-LUMEN INTERSTITIAL BREAST BALLOON USED FOR APBI? Bieleda, G.
 2012
 103 S2 p. S126-
1 p.
 artikel
149 PO-175 CATHETER POSITION CONTROL IN HIGH DOSE RATE BRACHYTHERAPY OF PROSTATE CANCER Marolt, P.
 2012
 103 S2 p. S71-S72
2 p.
 artikel
150 PO-383 CESIUM-131 BRACHYTHERAPY FOR HEAD AND NECK CANCERS: FIRST REPORT OF OUTCOMES, TOXICITY AND RADIATION EXPOSURE Parashar, B.
 2012
 103 S2 p. S153-
1 p.
 artikel
151 PO-296 CLINICAL AND DOSIMETRIC RESULTS OF HDR BRACHYTHERAPY GUIDED WITH MRI Antonini, P.
 2012
 103 S2 p. S118-
1 p.
 artikel
152 PO-353 CLINICAL ASSESSMENT OF THE HDR CAPRIÔ APPLICATOR Steffey, B.
 2012
 103 S2 p. S142-
1 p.
 artikel
153 PO-265 CLINICAL CONSEQUENCES OF HDR SOURCE ANISOTROPY IN VAGINAL CYLINDER TREATMENTS Bus, S.J.E.A.
 2012
 103 S2 p. S106-S107
2 p.
 artikel
154 PO-310 CLINICAL FEASIBILITY OF COBALT 60 HDR INTRACAVITARY BRACHYTHERAPY IN CARCINOMA CERVIX: A PRELIMINARY REPORT Basu, A.
 2012
 103 S2 p. S124-
1 p.
 artikel
155 PO-235 CLINICAL OUTCOME AND DOSIMETRIC PARAMETERS OF MRI-GUIDED BRACHYTHERAPY IN CERVICAL CANCER PATIENTS Nomden, C.N.
 2012
 103 S2 p. S95-
1 p.
 artikel
156 PO-180 CLINICAL OUTCOME OF 195 LOW OR INTERMEDIATE RISK PROSTATE CANCER TREATED BY PERMANENT IMPLANT BRACHYTHERAPY Verry, C.
 2012
 103 S2 p. S73-
1 p.
 artikel
157 PO-258 CLINICAL RESULTS OF VAGINAL BRACHYTHERAPY DELIVERED WITH A RING APPLICATOR FOR ENDOMETRIAL CANCER Meijnen, P.
 2012
 103 S2 p. S104-
1 p.
 artikel
158 PO-227 C4 MARKERS FOR MRI-BASED PROSTATE BRACHYTHERAPY Frank, S.
 2012
 103 S2 p. S91-
1 p.
 artikel
159 PO-302 COMBINATION OF EXTERNAL BEAM IRRADIATION AND LOW-DOSE RATE BRACHYTHERAPY FOR INOPERABLE ENDOMETRIAL CARCINOMAS Baumann, A.
 2012
 103 S2 p. S121-
1 p.
 artikel
160 PO-384 COMBINED EXTERNAL BEAM RADIOTHERAPY AND INTRALUMINAL BRACHYTHERAPY IN THE TREATMENT OF ESOPHAGEAL CANCER Scepanovic, D.
 2012
 103 S2 p. S153-
1 p.
 artikel
161 PO-395 COMBINED EXTERNAL RADIOTHERAPY AND I-125 PARTICLE IMPLANTATION FOR TREATMENT OF HEADAND NECK CANCERS Liu, S.M.
 2012
 103 S2 p. S157-S158
2 p.
 artikel
162 PO-270 COMPARING CLASSIC AND MULTICHANNEL CYLINDRICAL VAGINAL APPLICATORS IN INTRACAVITARY GYNAECOLOGIC BRACHYTHERAPY Cerrotta, A.
 2012
 103 S2 p. S108-S109
2 p.
 artikel
163 PO-343 COMPARISION OF TG-43 AND ACUROS DOSE CALCULATION ALGORITHM FOR VARIOUS APPLICATORS USED IN HDR GYN BRACHYTHERAPY Swamidas, J.
 2012
 103 S2 p. S138-
1 p.
 artikel
164 PO-369 COMPARISON OF 60 GY AND 54 GY IN HIGH-DOSE-RATE INTERSTITIAL BRACHYTHERAPY FOR EARLY ORAL TONGUE CANCER Akiyama, H.
 2012
 103 S2 p. S148-
1 p.
 artikel
165 PO-262 COMPARISON OF HDR INTRACAVITARY BRACHYTHERAPY DOSIMETRY WITH AND WITHOUT ANESTHESIA IN CERVICAL CARCINOMA Chaudhari, P.
 2012
 103 S2 p. S105-S106
2 p.
 artikel
166 PO-198 COMPARISON OF TREATMENT PLAN PARAMETERS IN BRACHYTHERAPY OF PROSTATE CANCER IN DIFFERENT SCHEDULES Kanikowski, M.
 2012
 103 S2 p. S80-
1 p.
 artikel
167 PO-250 CONCURRENT CHEMORADIOTHERAPY WITH HDR INTRACAVITARY BRACHYTHERAPY FOR CERVICAL CANCER: A PHASE II STUDY Toita, T.
 2012
 103 S2 p. S101-
1 p.
 artikel
168 PO-388 CONTACTHERAPY FOR CARCINOMA OF THE EYELID: A REPORT OF 29 CASES. Benezery, K.
 2012
 103 S2 p. S154-S155
2 p.
 artikel
169 PO-324 CONTRAINDICATIONS TO BREAST INTERSTITIAL BRACHYTHERAPY AFTER CONSERVATIVE SURGERY Stas, N.
 2012
 103 S2 p. S129-
1 p.
 artikel
170 PO-184 CORRELATION OF A BIOEFFECT MODEL WITH TUMOUR CONTROL IN LOCALISED PROSTATE CANCER TREATED WITH I-125 IMPLANT Haworth, A.
 2012
 103 S2 p. S75-
1 p.
 artikel
171 PO-323 COSMETIC OUTCOME AFTER INTRA-OPERATIVE RADIOTHERAPY FOR EARLY BREAST CANCER IN WOMEN OVER 50 YEARS Williams, N.
 2012
 103 S2 p. S128-S129
2 p.
 artikel
172 PO-407 CT-GUIDED INTERSTITIAL HDR-BRT FOR RECURRENT MALIGNANT GLIOMAS: FIFTEEN YEARS SINGLE INSTITUTE EXPERIENCE Tselis, N.
 2012
 103 S2 p. S162-
1 p.
 artikel
173 PO-256 CT IMAGE GUIDED LOW DOSE RATE BRACHYTHERAPY FOR CERVICAL CANCER: TRANSITIONING FROM 2D TO 3D, ARE WE THERE YET? Nelson, C.
 2012
 103 S2 p. S103-
1 p.
 artikel
174 PO-172 CURRENT RISK CLASSIFICATION FOR PROSTATE CANCER DOES NOT ACCURATELY PREDICT SURVIVAL AFTER I-125 BRACHYTHERAPY Kerkmeijer, L.
 2012
 103 S2 p. S70-S71
2 p.
 artikel
175 PO-240 DAILY HDR BRACHYTHERAPY IN THE POSTOPERATIVE SETTING OF ENDOMETRIAL CARCINOMA Rovirosa, A.
 2012
 103 S2 p. S97-
1 p.
 artikel
176 PO-160 DAILY NEEDLE APPLICATOR DISPLACEMENT DURING HIGH-DOSE-RATE PROSTATE BRACHYTHERAPY USING DAILY CT EXAMINATIONS Takenaka, T.
 2012
 103 S2 p. S66-
1 p.
 artikel
177 PO-305 3D BALANCED STEADY-STATE FREE PRECESSION (3D-BSSFP) MRI INTERSTITIAL CATHETER IDENTIFICATION Viswanathan, A.
 2012
 103 S2 p. S122-
1 p.
 artikel
178 PO-285 3D COMPUTED TOMOGRAPHY GUIDED IMAGE BASED INTERSTITIAL BRACHYTHERAPY FOR CANCER OF CERVIX Sharma, S.
 2012
 103 S2 p. S114-
1 p.
 artikel
179 PO-267 3D DOSIMETRY OF THE BLADDER FILLING IN HDR VAGINAL CUFF BRACHYTHERAPY Kobzda, J.
 2012
 103 S2 p. S107-S108
2 p.
 artikel
180 PO-257 DEEP VENOUS THROMBOSIS (DVT) RATES IN PATIENTS RECEIVING BRACHYTHERAPY FOR CERVICAL CANCER Caley, A.
 2012
 103 S2 p. S103-S104
2 p.
 artikel
181 PO-273 DETERMINING DOSIMETRIC FACTORS RELATED TO LOCAL CONTROL IN CT-BASED BRACHYTHERAPY Kaplan, S.
 2012
 103 S2 p. S110-
1 p.
 artikel
182 PO-149 DEVELOPMENT OF A PRACTICAL PROSTATE BRACHYTHERAPY TRAINING PHANTOM Forsythe, K.
 2012
 103 S2 p. S62-
1 p.
 artikel
183 PO-236 3D IMAGE BASED VS. POINT BASED DOSIMETRY FOR CERVICAL CANCER: EARLY OUTCOME ANALYSIS Kannan, N.
 2012
 103 S2 p. S95-S96
2 p.
 artikel
184 PO-299 3D MRI-BASED HDR-BRACHYTHERAPY PLANNING AND IMRT FOR THE TREATMENT OF CERVICAL CANCER Dyk, P.T.
 2012
 103 S2 p. S119-
1 p.
 artikel
185 PO-171 DNA PLOIDY BASED ON ARCHIVED BIOPSY MATERIAL MAY CORRELATE WITH PSA RECURRENCE AFTER PROSTATE BRACHYTHERAPY Keyes, M.
 2012
 103 S2 p. S70-
1 p.
 artikel
186 PO-220 DOSE ESCALATION TO 160 GY IN I-125 PROSTATE IMPLANTS. EARLY CLINICAL RESULTS Tormo, A.
 2012
 103 S2 p. S88-
1 p.
 artikel
187 PO-234 DOSE OPTIMIZATION OF INTRA-VAGINAL BRACHYTHERAPY USING DIFFERENT MULTI-CHANNEL APPLICATORS Kuo, H.
 2012
 103 S2 p. S94-S95
2 p.
 artikel
188 PO-263 DOSE-VOLUME PARAMETERS IN CT-BASED IMAGE-GUIDED BRACHYTHERAPY FOR CERVICAL CANCER Ando, K.
 2012
 103 S2 p. S106-
1 p.
 artikel
189 PO-329 DOSIMETRIC ANALYSIS OF A THERMOBRACHYTHERAPY APPLICATOR IN THE CONTEXT OF A POSITIONING REPRODUCIBILITY STUDY Sánchez Mazón, J.
 2012
 103 S2 p. S130-S131
2 p.
 artikel
190 PO-321 DOSIMETRIC COMPARISON BETWEEN 2D DOSE POINT AND 3D CT-BASED VOLUME OPTIMIZATION IN BREAST BOOST HDR BRACHYTHERAPY Gruszczynska, E.
 2012
 103 S2 p. S128-
1 p.
 artikel
191 PO-382 DOSIMETRIC COMPARISON OF 131CS VERSUS 125I INTRAOPERATIVE BRACHYTHERAPY FOR THE TREATMENT RESECTED BRAIN TUMORS Wernicke, A.G.
 2012
 103 S2 p. S152-
1 p.
 artikel
192 PO-300 DOSIMETRIC COMPARISON OF 2D AND 3D BRACHYTHERAPY PLANNING Kemikler, G.
 2012
 103 S2 p. S119-S120
2 p.
 artikel
193 PO-238 DOSIMETRIC COMPARISON OF OPTIMISATION METHODS FOR MULTICHANNEL INTRACAVITARY VAGINAL BRACHYTHERAPY Lapuz, C.
 2012
 103 S2 p. S96-
1 p.
 artikel
194 PO-334 DOSIMETRIC CONSEQUENCES OF ROTATIONAL ERRORS WITH DIRECT SIMULATION FOR PARTIAL BREAST IRRADIATION USING CONTURAÔ Peng, J.
 2012
 103 S2 p. S133-S134
2 p.
 artikel
195 PO-155 DOSIMETRIC CONSTRAINT OPTIMIZATION IN INTRA-OPERATIVE TREATMENT PLANNING OF PERMANENT SEED IMPLANTATION (PSI) Kasch, K.U.
 2012
 103 S2 p. S64-
1 p.
 artikel
196 PO-237 DOSIMETRIC EFFECTS OF RECTAL FILLING ON VAGINAL CYLINDER BRACHYTHERAPY Sabater, S.
 2012
 103 S2 p. S96-
1 p.
 artikel
197 PO-295 DOSIMETRIC GAIN OF UTRECHT INTERSTITIAL CT/MRI APPLICATOR IN CERVICAL CANCER HDR-BRACHYTHERAPY Camacho, C.
 2012
 103 S2 p. S118-
1 p.
 artikel
198 PO-274 DOSIMETRIC IMPACT OF CTS WITH EACH FRACTION ON ORGANS AT RISK FOR HDR VAGINAL CYLINDER BRACHYTHERAPY Zhu, L.
 2012
 103 S2 p. S110-
1 p.
 artikel
199 PO-309 DOSIMETRIC IMPACT OF INTERFRACTION CATHETER MOVEMENT IN MRI CT GUIDED HDR INTERSTITIAL BRACHYTHERAPY FOR GYN CANCER Rey, F.
 2012
 103 S2 p. S123-S124
2 p.
 artikel
200 PO-340 DOSIMETRIC IMPACT OF NOT CORRECTING FOR THE DISTAL SHIFT REPORTED IN VARIAN TANDEM AND RING (T&R) APPLICATORS Craciunescu, O.
 2012
 103 S2 p. S137-
1 p.
 artikel
201 PO-317 DOSIMETRIC IMPACTS OF TISSUE INHOMOGENEITIES IN ACCELERATED PARTIAL BREAST TREATMENTS USING HDR BRACHYTHERAPY Narra, V.
 2012
 103 S2 p. S126-S127
2 p.
 artikel
202 PO-354 DOSIMETRIC IMPACTS OF UPGRADING FROM PLATO TO ONCENTRABRACHY IN A HIGH VOLUME PROSTATE HDR BRACHY-THERAPY CENTER Lacroix, F.
 2012
 103 S2 p. S142-S143
2 p.
 artikel
203 PO-357 DOSIMETRIC IMPLICATIONS TO VAGINAL SURFACE DOSE OF PLANNING OPTIMIZATION METHODS Damato, A.
 2012
 103 S2 p. S144-
1 p.
 artikel
204 PO-405 EARLY INTERVENTION WITH SELECTIVE INTERNAL RADIATION THERAPY (SIRT) IMPROVES SURVIVAL AND LOCAL/SYSTEMIC OPTIONS Sharma, N.
 2012
 103 S2 p. S161-
1 p.
 artikel
205 PO-245 EFFECT OF BLADDER DISTENSION ON DOSIMETRY OF ORGAN AT RISK IN CT BASED PLANNING OF HDR ICBT FOR CERVICAL CANCER Sazzad Manir, K.
 2012
 103 S2 p. S99-
1 p.
 artikel
206 PO-176 EFFICACY, TOXICITY AND DOSIMETRIC ASPECTS OF HDR BRACHYTHERAPY IN PROSTATE CANCER PATIENTS: 5 YEARS EXPERIENCE Filipowski, T.M.
 2012
 103 S2 p. S72-
1 p.
 artikel
207 PO-386 ENDOBRONCHIAL BRACHYTHERAPYAS ADJUVANT TREATMENTIN PRIMARY BRONCHIAL N.S.C.L.C TUMORS Papalla, K.
 2012
 103 S2 p. S154-
1 p.
 artikel
208 PO-379 ENDOLUMINAL HIGH DOSE RATE BRACHYTHERAPY FOR EARLY STAGE AND RECURRENT ESOPHAGEAL CANCER Folkert, M.R.
 2012
 103 S2 p. S151-
1 p.
 artikel
209 PO-403 ENDOSCOPIC GUIDED BRACHYTHERAPY (EGBT) FOR SINONASAL AND NASOPHARYNGEAL RECURRENCES Bussu, F.
 2012
 103 S2 p. S160-S161
2 p.
 artikel
210 PO-298 ESTIMATION OF BOWEL DOSE FOR ENDOMETRIAL CARCINOMA TREATED BY HIGH DOSE RATE BRACHYTHERAPY ALONE – INITIAL RESULTS Zuchora, A.
 2012
 103 S2 p. S119-
1 p.
 artikel
211 PO-372 EVALUATION OF BIODEGRADABLE MAGNESIUM ALLOY AZ31 AS A NEW CONNECTING MATERIAL FOR IODINE-125 BRACHYTHERAPY Fu Jun, Z.
 2012
 103 S2 p. S149-
1 p.
 artikel
212 PO-304 EVALUATION OF 3D MRI CUBE TECHNIQUE FOR HDR CERVICAL CANCER TREATMENT Kim, H.
 2012
 103 S2 p. S121-S122
2 p.
 artikel
213 PO-313 EVALUATION OF IN VIVO DOSIMETRY IN BREAST CANCER BRACHYTHERAPY USING MOSFET DETECTORS Nahajowski, D.
 2012
 103 S2 p. S125-
1 p.
 artikel
214 PO-348 EVALUATION OF THE TRACHEA INHOMOGENETY EFFECT ON DOSE CALCULATIONS OF ESOPHAGUS HDR BRACHYTHERAPY Hosseini Daghigh, S.M.
 2012
 103 S2 p. S140-
1 p.
 artikel
215 PO-170 EXCLUSIVE IODINE 125 PROSTATE BRACHYTHERAPY. EXPERIENCE OF INSTITUT BERGONIÈ Thomas, L.
 2012
 103 S2 p. S70-
1 p.
 artikel
216 PO-152 EXPLORING THE DOSIMETRIC AND RADIOBIOLOGICAL EFFECTS OF PROSTATE SEED LOSS AND MIGRATION Knaup, C.
 2012
 103 S2 p. S63-
1 p.
 artikel
217 PO-269 EXTERNAL BEAM RADIOTHERAPY AND BRAQUITHERAPY ASSOCIATED CHEMOTHERAPY, IN IIB-IV CANCER OF THE CERVIX Mercedes, Z.
 2012
 103 S2 p. S108-
1 p.
 artikel
218 PO-326 FAST MONTE CARLO HDR DOSE CALCULATIONS WITH BGPUMCD Hissoiny, S.
 2012
 103 S2 p. S129-S130
2 p.
 artikel
219 PO-364 FIRST EXPERIENCE WITH HIGH-DOSE RATE INTERSTITIAL BRACHYTHERAPY IN THE TREATMENT OF PENILE CARCINOMA Petera, J.
 2012
 103 S2 p. S147-
1 p.
 artikel
220 PO-154 FOCAL BRACHYTHERAPY FOR PROSTATE CANCER: A PILOT STUDY Cosset, J.M.
 2012
 103 S2 p. S64-
1 p.
 artikel
221 PO-165 FOCAL THERAPY FOR PROSTATE CANCER RECURRENCES: FEASIBILITY, TOXICITY AND QUALITY OF LIFE OF I-125 FOCAL SALVAGE van Vulpen, M.
 2012
 103 S2 p. S67-S68
2 p.
 artikel
222 PO-306 FROM 2D RADIOGRAPH-BASED TO 3D CT- BASED PLANNING IN CERVICAL CANCER BRACHYTHERAPY-WARSAW EXPERIENCE Dabkowski, M.
 2012
 103 S2 p. S122-
1 p.
 artikel
223 PO-248 GYNAECOLOGICAL BRACHYTHERAPY: USING A SPREADING APPLICATOR TO INDIVIDUALIZE DOSE TO THE VAGINAL APEX Biesta, J.
 2012
 103 S2 p. S100-
1 p.
 artikel
224 PO-311 HDR-AFTERLOADING FOR BREAST IORT USING A BALLOON CATHETER APPLICATOR Schleicher, U.
 2012
 103 S2 p. S124-
1 p.
 artikel
225 PO-221 HDR BRACHYTHERAPY BOOST AND EXTERNAL RADIOTHERAPY FOR UNFAVORABLE PROSTATE CANCER PATIENTS Monteiro Grillo, I.
 2012
 103 S2 p. S88-S89
2 p.
 artikel
226 PO-174 HDR BRACHYTHERAPY BOOST FOR LOCALISED PROSTATE CANCER: THE FIRST 150 PATIENTS FROM THE SYDNEY CANCER CENTRE. Whalley, D.
 2012
 103 S2 p. S71-
1 p.
 artikel
227 PO-373 HDR BRACHYTHERAPY BOOST FOR LOCALLY ADVANCED RECTAL CARCINOMA FOLLOWING EBCRT-CLATTERBRIDGE EXPERIENCE Sun Myint, A.
 2012
 103 S2 p. S149-
1 p.
 artikel
228 PO-249 HDR BRACHYTHERAPY BOOST IN GYNAECOLOGICAL CANCERS, WHAT'S THE PERFECT TIMING TO PREVENT VAGINAL STENOSIS? Piro, F.
 2012
 103 S2 p. S100-S101
2 p.
 artikel
229 PO-254 HDR BRACHYTHERAPY FOR HIGH GRADE VAGINAL INTRAEPITHELIAL NEOPLASIA Mhlanga, S.H.
 2012
 103 S2 p. S102-
1 p.
 artikel
230 PO-319 HDR BRACHYTHERAPY FOR LOCAL RECURRENCES AFTER PRIOR BREAST RADIOTHERAPY: FEASIBILITY AND PRELIMINARY RESULTS Vavassori, A.
 2012
 103 S2 p. S127-
1 p.
 artikel
231 PO-402 HDR BRACHYTHERAPY GIVES RAPID TUMOR RESPONSE AND LOW NORMAL TISSUE TOXICITY IN NON-MELANOMA SKIN CANCER OF THE FACE Kumar, R.
 2012
 103 S2 p. S160-
1 p.
 artikel
232 PO-413 HDR BRACHYTHERAPY IN ADVANCED ESOPHAGEAL CANCER: IMPROVEMENT OF DYSPHAGIA IN A COHORT OF 108 PATIENTS Reisner, M.L.
 2012
 103 S2 p. S164-
1 p.
 artikel
233 PO-308 HDR BRT IN ENDOMETRIAL CANCER: EXPERIENCE OF TWO FRACTIONATION SCHEDULES AND RESULTS OF 14 YEARS WITH 57 PATIENTS Gribaudo, S.
 2012
 103 S2 p. S123-
1 p.
 artikel
234 PO-399 HDR INTENSTINAL BRACHYTERAPY AS A SALVAGE TREATMENT IN RECTAL ADENOCARCINOMA PATIENTS Filipowski, T.
 2012
 103 S2 p. S158-S159
2 p.
 artikel
235 PO-197 HIGH DEFINITION CUSTOMISED BRACHYTHERAPY FOR PROSTATE CANCER BASED ON TRANSPERINEAL SECTOR MAPPING BIOPSIES Morris, S.L.
 2012
 103 S2 p. S79-S80
2 p.
 artikel
236 PO-377 HIGH DOSE RATE BRACHYTEHERAY IN SOFT TISSUE SARCOMAS OF THE EXTREMITIES AS PART OF THE TREATMENT SEQUENCE Montenero, G.
 2012
 103 S2 p. S150-S151
2 p.
 artikel
237 PO-193 HIGH DOSE RATE BRACHYTHERAPY AS MONOTHERAPY FOR EARLY-STAGE PROSTATE CANCER: TOXICITY AND EARLY RESULTS Aluwini, S.
 2012
 103 S2 p. S78-
1 p.
 artikel
238 PO-325 HIGH-DOSE RATE BRACHYTHERAPY FOR EARLY BREAST CANCER: DOSIMETRIC DATA AND COSMETIC EFFECT Italiani, M.
 2012
 103 S2 p. S129-
1 p.
 artikel
239 PO-408 HIGH DOSE RATE 3-DIMENSIONAL TOPOGRAPHIC APPLICATOR BRACHY-THERAPY FOR SKIN CANCER ABOVE CLAVICLE: EARLY OUTCOMES Vyas, S.
 2012
 103 S2 p. S162-S163
2 p.
 artikel
240 PO-366 HIGH-DOSE-RATE INTERSTITIAL BRACHYTHERAPY AS A MONOTHERAPY FOR ANTERIOR MOBILE TONGUE CANCER Yoshida, K.
 2012
 103 S2 p. S147-S148
2 p.
 artikel
241 PO-255 HIGH DOSE-RATE INTERSTITIAL BRACHYTHERAPY FOR GYNECOLOGICAL MALIGNANCIES Murakami, N.
 2012
 103 S2 p. S102-S103
2 p.
 artikel
242 PO-275 HIGH-DOSE-RATE VAGINAL BRACHYTHERAPY ALONE IN ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA: 24 GRAY IN 6 FRACTIONS Townamchai, K.
 2012
 103 S2 p. S110-S111
2 p.
 artikel
243 PO-177 HISTOSCANNING BASED DOSE ESCALATION FOR PROSTATE CANCER AS MICROBOOST USING BRACHYTHERAPY – A PHASE II-TRIAL Lettmaier, S.
 2012
 103 S2 p. S72-
1 p.
 artikel
244 PO-418 HYPOFRACTIONATED ACCELERATED CT-GUIDED INTERSTITIAL HIGH-DOSE-RATE BRACHYTHERAPY FOR LIVER MALIGNANCIES Tselis, N.
 2012
 103 S2 p. S166-S167
2 p.
 artikel
245 PO-218 125I BRACHYTHERAPY AS A CURE FOR EARLY STAGE PROSTATE CANCER IN PATIENTS UNDER 65 YEARS OF AGE Palloni, T.
 2012
 103 S2 p. S88-
1 p.
 artikel
246 PO-396 I-125 BRACHYTHERAPY FOR LOCALLY RECURRENT PAROTID GLAND CANCER IN PREVIOUSLY IRRADIATED PATIENTS Zheng, L.
 2012
 103 S2 p. S158-
1 p.
 artikel
247 PO-297 IMAGE-GUIDED BRACHYTHERAPY FOR THE TREATMENT OF CERVICAL CANCER: RESULTS ON DIFFERENT PACKING TECHNIQUES Libby, B.
 2012
 103 S2 p. S118-S119
2 p.
 artikel
248 PO-420 IMAGE-GUIDED INTERSTITIAL HDR-BRACHYTHERAPY IN THE LOCAL TREATMENT OF INTRATHORACIC MALIGNANCIES Tselis, N.
 2012
 103 S2 p. S167-
1 p.
 artikel
249 PO-371 IMAGE-GUIDED IODINE-125 PERMANENT IMPLANTATION AS SALVAGE THERAPY FOR RECURRENT HEAD AND NECK CARCINOMA Wang, J.
 2012
 103 S2 p. S149-
1 p.
 artikel
250 PO-251 IMPACT OF BLADDER DISTENSION ON ORGANS AT RISK IN 3D INTRACAVITARY BRACHYTHERAPY FOR GYNECOLOGICAL CANCER Bajwa, H.
 2012
 103 S2 p. S101-
1 p.
 artikel
251 PO-162 IMPACT OF DOSE ON INTERMEDIATE-RISK PROSTATE CANCER PATIENTS TREATED WITH BRACHYTHERAPY ALONE OR BOOST Yorozu, A.
 2012
 103 S2 p. S66-S67
2 p.
 artikel
252 PO-167 IMPACT OF EMBEDDED SEEDS ON DOSE DISTRIBUTIONS IN X-RAY RADIOTHERAPY: A PHANTOM STUDY WITH MONTE CARLO CALCULATION Shiraishi, K.
 2012
 103 S2 p. S68-S69
2 p.
 artikel
253 PO-219 IMPLEMENTATION OF INTRAOPERATIVE ULTRASOUND BASED REAL-TIME ADAPTIVE PLANNING FOR PROSTATE BRACHYTHERAPY D'Souza, D.
 2012
 103 S2 p. S88-
1 p.
 artikel
254 PO-216 IMPROVED ACUTE URINARY OUTCOMES IN PATIENTS TREATED WITH HDR VERSUS LDR MONOTHERAPY FOR PROSTATE CANCER Fernandez, D.C.
 2012
 103 S2 p. S87-
1 p.
 artikel
255 PO-394 IMPROVED CTV DOSE HOMOGENEITY AND NORMAL TISSUE MAXIMUM DOSE FOR ESOPHAGEAL HDR USING A THREE TUBE TECHNIQUE Greskovich, J.
 2012
 103 S2 p. S157-
1 p.
 artikel
256 PO-226 INCORPORATING EDEMA IN PROSTATE SEED IMPLANT DOSIMETRY USING A CLINICALLY-INFORMED EDEMA MODEL Liu, D.
 2012
 103 S2 p. S91-
1 p.
 artikel
257 PO-264 INITIAL CLINICAL FOLLOW-UP ON THE USE OF A CO-60 HDR SOURCE FOR CERVICAL CANCER BRACHYTHERAPY Nagar, Y.
 2012
 103 S2 p. S106-
1 p.
 artikel
258 PO-361 INNOVATIVE APPROACH FOR THE ACCURATE ABSORBED DOSE AT OARS AND THE DOSE DISTRIBUTION IN THE EYE FROM RU-106 PLAQUES Brualla, L.
 2012
 103 S2 p. S145-S146
2 p.
 artikel
259 PO-201 INSTITUTIONAL ANALYSIS OF OUTCOMES FOR STAGES T1-T2 PROSTATE CANCER TREATED WITH BRACHYTHERAPY Soares, A.
 2012
 103 S2 p. S81-S82
2 p.
 artikel
260 PO-350 INTENSE LEARNING OUTCOMES BASED BRACHYTHERAPY TRAINING FOR RADIATION ONCOLOGY MEDICAL PHYSICISTS Flower, E.
 2012
 103 S2 p. S141-
1 p.
 artikel
261 PO-233 INTENSITY MODULATED HIGH-DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER Tselis, N.
 2012
 103 S2 p. S94-
1 p.
 artikel
262 PO-330 INTEREST OF THE MONTE CARLO SIMULATIONS FOR DOSIMETRIC EVALUATION OF THE 50 KVP DEVICE “PAPILLON50” Croce, O.
 2012
 103 S2 p. S131-
1 p.
 artikel
263 PO-345 INTER-SEED ATTENUATION IN PROSTATE I-125 SEED IMPLANT BRACHYTHERAPY: EXPERIMENTAL AND CLINICAL INVESTIGATION Bownes, P.
 2012
 103 S2 p. S139-
1 p.
 artikel
264 PO-389 INTERSTITIAL PERMANENT IMPLANTATION OF 125 I SEEDS FOR REFRACTORY CHEST WALL MATASTASIS OR RECURRENCE Jiang, P.
 2012
 103 S2 p. S155-
1 p.
 artikel
265 PO-341 INTRANASAL MOLD HDR BRACHYTHERAPY FOR NASAL VESTIBULE CANCER: ANALYSIS OF HETEROGENEITY CORRECTION Crandley, E.F.
 2012
 103 S2 p. S137-
1 p.
 artikel
266 PO-390 INTRAOPERATIVE AND PERCUTANEOUS IR-192 BRACHYTHERAPY FOR MULTIPLY IRRADIATED LESIONS OF THE SPINE Yamada, Y.
 2012
 103 S2 p. S155-S156
2 p.
 artikel
267 PO-391 INTRAOPERATIVE BRACHYTHERAPY FOR THORACIC MALIGNANCIES RESECTED WITH CLOSE OR POSITIVE MARGINS Wu, A.J.
 2012
 103 S2 p. S156-
1 p.
 artikel
268 PO-419 INTRAOPERATIVE HIGH DOSE RATE INTERSTITIAL BRACHYTHERAPY IN THE MANAGEMENT OF SOFT TISSUE SARCOMAS Varela Cagetti, L.
 2012
 103 S2 p. S167-
1 p.
 artikel
269 PO-182 INTRA-OPERATIVE REAL-TIME PLANNED PERMANENT-SEED PROSTATE BT: IMPACT OF TRAINING PROGRAM AND LEARNING CURVE Zilli, T.
 2012
 103 S2 p. S74-
1 p.
 artikel
270 PO-335 INVERSE PLANNING OF CONFORMAL HDR-PROSTATE BRACHYTHERAPY BOOST TECHNIQUE USING TWO CTVS Wolf, S.
 2012
 103 S2 p. S134-
1 p.
 artikel
271 PO-344 IN-VIVO DOSIMETRY IN HDR BRACHYTHERAPY: THE EFFECT OF TEMPERATURE VARIATION AND SIMULATED POSITION CHANGES Hayman, O.
 2012
 103 S2 p. S138-S139
2 p.
 artikel
272 PO-212 IODINE-125 BRACHYTHERAPY: PSA NADIR LESS THAN 1NG/ML AS PROGNOSTIC FACTOR Castilho, L.
 2012
 103 S2 p. S85-S86
2 p.
 artikel
273 PO-173 IODINE-125 (I-125) LOW DOSE RATE (LDR) BRACHYTHERAPY FOR HIGHER RISK (HR) PROSTATE CANCER Conroy, R.
 2012
 103 S2 p. S71-
1 p.
 artikel
274 PO-266 IS AN MRI REQUIRED ON EACH FRACTION? AN EXPERIENCE WITH MRI-GUIDED BRACHYTHERAPY FOR CERVICAL CANCE Chino, J.
 2012
 103 S2 p. S107-
1 p.
 artikel
275 PO-242 125I SEED PERMANENT IMPLANTATION FOR PELVIC RECURRENT GYNECOLOGICAL MALIGNANCIES AFTER MULTIPLE THERAPY Jiang, W.
 2012
 103 S2 p. S98-
1 p.
 artikel
276 PO-393 125I SEEDS BRACHYTHERAPY TO TREAT MALIGNANT SUBLINGUAL GLAND TUMORS Shi, Y.
 2012
 103 S2 p. S157-
1 p.
 artikel
277 PO-332 IS HDR EQUIPMENT PERFORMANCE SUITABLE FOR MODERN BRACHYTHERAPY? POSITIONAL ERRORS, DOSIMETRIC IMPACT & CASE STUDY Palmer, A.
 2012
 103 S2 p. S132-S133
2 p.
 artikel
278 PO-243 LATE TOXICITY AND TOLERANCE OF THE VAGINAL VAULT TO INTRACAVITARY HIGH DOSE RATE BRACHYTHERAPY Kaidar-Person, O.
 2012
 103 S2 p. S98-
1 p.
 artikel
279 PO-204 LDRBT IN LOW RISK PROSTATE ADENOCARCINOMA. 145 GY. VS 160 GY. LONG TERM RESULTS AND TOXICITY Depiaggio, M.
 2012
 103 S2 p. S82-S83
2 p.
 artikel
280 PO-161 LDR PROSTATE DOSIMETRY AND DOCUMENTATION FOCUS STUDY Cirino, E.
 2012
 103 S2 p. S66-
1 p.
 artikel
281 PO-415 LOCAL CONTROL, SURVIVAL AND COMPLICATIONS OF SOFT TISSUE SARCOMAS TREATED WITH LOW OR HIGH DOSE RATE BRACHYTHERAPY Paul, A.
 2012
 103 S2 p. S165-
1 p.
 artikel
282 PO-409 LOCAL EXCISION AND BRACHYTHERAPY FOR SPHINCTER PRESERVATION IN RECTAL CANCER: RESULTS ON A COHORT OF 70 PATIENTS Grimard, L.
 2012
 103 S2 p. S163-
1 p.
 artikel
283 PO-224 LONG TERM EXPERIENCE OF HDR BOOST FOR LOCALIZED PROSTATE USING INVERSE PLANNING WITH SIMULATED ANNEALING Vigneault, E.
 2012
 103 S2 p. S90-
1 p.
 artikel
284 PO-151 LONG TERM RESULTS OF HDR BRACHYTHERAPY IN MEN OLDER THAN 75 WITH LOCALIZED CARCINOMA OF THE PROSTATE Soumarova, R.
 2012
 103 S2 p. S63-
1 p.
 artikel
285 PO-202 LONG TERM RESULTS WITH MULTIMODALITY RADIOTHERAPY (3D, IGRT, LDRBT, HDRBT) IN PROSTATE ADENOCARCINOMA Rodríguez Villalba, S.
 2012
 103 S2 p. S82-
1 p.
 artikel
286 PO-159 LONG TERM TOXICITY FOLLOWING CS-131 PROSTATE BRACHYTHERAPY Smith, R.P.
 2012
 103 S2 p. S65-S66
2 p.
 artikel
287 PO-231 LOW DOSE RATE BRACHYTHERAPY IS AN EXCELLENT TREATMENT OPTION FOR YOUNG MEN WITH LOCALISED PROSTATE CANCER Laing, R.
 2012
 103 S2 p. S93-
1 p.
 artikel
288 PO-186 LOW DOSE RATE BRACHYTHERAPY WITH PERMANENT SEEDS OF I-125 IN PROSTATE CANCER. CLINICAL AND DOSIMETRIC ANALYSIS Gentil Jiménez, M.A.
 2012
 103 S2 p. S75-S76
2 p.
 artikel
289 PO-316 LUMEN LENGTH VARIATIONS ON THE CONTURATM APPLICATOR FOR BREAST BRACHYTHERAPY Lee, C.
 2012
 103 S2 p. S126-
1 p.
 artikel
290 PO-387 MANCHESTER SYSTEM TREATMENTS TO THE SKIN SURFACE; FROM RADIUM TO IRIDIUM HDR (1953 TO 2012) Wood, D.
 2012
 103 S2 p. S154-
1 p.
 artikel
291 PO-337 MAPPING OF RELATIVE DOSE RATE DISTRIBUTION UNCERTAINTY OWING TO SOURCE CONSTRUCTION Zourari, K.
 2012
 103 S2 p. S135-
1 p.
 artikel
292 PO-346 MEASUREMENTS AROUND AN ELECTRONIC BRACHYTHERAPY SOURCE USING LITHIUM FORMATE EPR DOSIMETERS AND GAFCHROMIC FILM Adolfsson, E.
 2012
 103 S2 p. S139-
1 p.
 artikel
293 PO-342 MEASUREMENTS OF AN ELECTRONIC BRACHYTHERAPY SOURCE WITH A BRACHYTHERAPY DOSE VERIFICATION PHANTOM Pike, T.
 2012
 103 S2 p. S137-S138
2 p.
 artikel
294 PO-327 MIXED INTEGER PROGRAMMING FOR DOSE AND DOSE-VOLUME BASED OPTIMIZATION IN PROSTATE HDR-BRACHYTHERAPY Gorissen, B.L.
 2012
 103 S2 p. S130-
1 p.
 artikel
295 PO-352 MODULATION RESTRICTIONS DO NOT NECESSARILY IMPROVE TREATMENT PLAN QUALITY FOR HDR PROSTATE BRACHYTHERAPY Balvert, M.
 2012
 103 S2 p. S142-
1 p.
 artikel
296 PO-401 MRI-BASED RECTAL APPLICATOR RECONSTRUCTION IN HDR RECTAL BRACHYTHERAPY Beiki-Ardakani, A.
 2012
 103 S2 p. S159-S160
2 p.
 artikel
297 PO-339 MRI-DUMMY MARKERS OF MRI-GUIDED HDR BRACHYTHERAPY FOR INTERSTITIAL PROSTATE AND INTRACAVITARY GYN CANCERS Schindel, J.
 2012
 103 S2 p. S136-
1 p.
 artikel
298 PO-289 MULTICHANNEL VAGINAL BRACHYTHERAPY: OVERKILL OR NECESSITY? Park, S.
 2012
 103 S2 p. S115-S116
2 p.
 artikel
299 PO-196 NATURAL DOSE VOLUME HISTOGRAM: RELATION WITH VOLUME OF TARGET AND SEEDS PER NEEDLE IN PERMANENT PROSTATE IMPLANTS Martinez Cobo, R.
 2012
 103 S2 p. S79-
1 p.
 artikel
300 PO-283 NEOADJUVANT OR ADJUVANT BRACHYTHERAPY FOR CORPUS UTERI CANCER PATIENTS AT LOW RISK Mavrichev, S.
 2012
 103 S2 p. S113-
1 p.
 artikel
301 PO-328 NEW DESIGN OF THE VALENCIA APPLICATORS TO REDUCE RADIATION LEAKAGE Granero, D.
 2012
 103 S2 p. S130-
1 p.
 artikel
302 PO-406 NON MELANOMA SKIN CANCER TREATED WITH SUPERFICIAL BRACHYTHERAPY (BQT) OF HIGH DOSE RATE (HDR) WITH LEIPZIG OR MOULD Villavicencio-Queijeiro, M.
 2012
 103 S2 p. S161-S162
2 p.
 artikel
303 PO-268 NOVEL MRI-MARKER-FLANGE FOR MRI-GUIDED BRACHYTHERAPY FOR GYNECOLOGICAL CANCER Schindel, J.
 2012
 103 S2 p. S108-
1 p.
 artikel
304 PO-215 ON THE EFFECTS OF DOSE HETEROGENEITIES ON THE ESTIMATION OF THE ALPHA/BETA RATIO FOR PROSTATE CANCER Afsharpour, H.
 2012
 103 S2 p. S86-S87
2 p.
 artikel
305 PO-260 OPTIMAL MAGNETIC RESONANCE IMAGING SEQUENCE FOR HIGH-DOSE-RATE BRACHYTHERAPY OF THE CERVIX Dempsey, C.
 2012
 103 S2 p. S105-
1 p.
 artikel
306 PO-284 OUR EXPERIENCE IN INITIAL 20 CASES OF CERVICAL CANCER WITH CT IMAGE BASED BRACHYTHERAPY TREATMENTS Carvalho, L.
 2012
 103 S2 p. S113-S114
2 p.
 artikel
307 PO-148 OUTCOME AND TOXICITY AFTER SALVAGE PROSTATECTOMY, CRYOSURGERY AND BRACHYTHERAPY FOR PROSTATE CANCER RECURRENCES Peters, M.
 2012
 103 S2 p. S61-S62
2 p.
 artikel
308 PO-312 OUTCOME OF TRIPLE NEGATIVE (TN) BREAST CARCINOMA AFTER BREAST CONSERVATION WITH RADIOTHERAPY Masood, U.
 2012
 103 S2 p. S124-S125
2 p.
 artikel
309 PO-292 OUTCOMES FOR CERVICAL AND VAGINAL CANCER WITH HDR INTERSTITIAL BRACHYTHERAPY UTILIZING MRI BASED PLANNING Freilich, J.M.
 2012
 103 S2 p. S117-
1 p.
 artikel
310 PO-293 OUTCOMES FOR RECURRENT ENDOMETRIAL CANCER WITH HDR INTERSTITIAL BRACHYTHERAPY UTILIZING MRI BASED PLANNING Biagioli, M.C.
 2012
 103 S2 p. S117-
1 p.
 artikel
311 PO-246 OVERALL SURVIVAL RATES IN LOCALLY ADVANCED CERVIX CANCER – A BRAZILIAN EXPERIENCE Campos, C.
 2012
 103 S2 p. S99-
1 p.
 artikel
312 PO-333 PARTICULARITIES OF I-125 SEED CALIBRATION FOR PROSTATE INTERSTITIAL PERMANENT BRACHYTHERAPY Tornero-López, A.
 2012
 103 S2 p. S133-
1 p.
 artikel
313 PO-370 PERCUTANEOUS ULTRASOUND-GUIDED IODINE-125 IMPLANTATION AS A SALVAGE THERAPY FOR RECURRENT LYMPH NODE METASTASES Wang, J.J.
 2012
 103 S2 p. S148-S149
2 p.
 artikel
314 PO-166 PERMANENT PROSTATE BRACHYTHERAPY IN JAPANESE PATIENTS WITH SMALL PROSTATE GLANDS Kobayashi, K.
 2012
 103 S2 p. S68-
1 p.
 artikel
315 PO-356 PERTURBATION EFFECT OF DWELL POSITION IN HIGH DOSE RATE BRACHYTHERAPY FOR ACCELERATED PARTIAL BREAST IRRADIATION Li, K.
 2012
 103 S2 p. S143-
1 p.
 artikel
316 PO-397 32P-FOILS FOR RADIOACTIVE IMPLANTS IN LOW-DOSE-RATE (LDR) BRACHYTHERAPY Assmann, W.
 2012
 103 S2 p. S158-
1 p.
 artikel
317 PO-365 PHASE II STUDY: CT-GUIDED INTERSTITIAL 60CO-HDR-BRACHYTHERAPY WITH MRI FUSION FOR BOOST HEAD AND NECK PATIENTS Lozhkov, A.
 2012
 103 S2 p. S147-
1 p.
 artikel
318 PO-158 PHASE II TRIAL OF HIGH-DOSE RATE BRACHYTHERAPY AND EXTERNAL RADIATION FOR INTERMEDIATE-RISK PROSTATE CANCER Tsukiyama, I.
 2012
 103 S2 p. S65-
1 p.
 artikel
319 PO-225 PLANNED TURP PRIOR TO LDR PROSTATE BRACHYTHERAPY DOES NOT CAUSE INCONTINENCE Chadwick, E.
 2012
 103 S2 p. S90-S91
2 p.
 artikel
320 PO-349 POSITIVE OUTCOMES OF T CELL SKIN LYMPHOMA USING HDR BRACHYTHERAPY FOR COMPLEX SKIN GEOMETRY Zakikhani, R.
 2012
 103 S2 p. S140-S141
2 p.
 artikel
321 PO-213 POST-IMPLANT DOSIMETRIC COMPARISON OF LOW, HIGH, AND VARIABLE STRENGTH IMPLANTS Spadinger, I.
 2012
 103 S2 p. S86-
1 p.
 artikel
322 PO-392 POSTOPERATIVE INTERSTITIAL PULSED-DOSE-RATE (PDR) BRACHYTHERAPY IN THE TREATMENT OF THERAPY-RESISTANT KELOIDS Davila Fajardo, R.
 2012
 103 S2 p. S156-S157
2 p.
 artikel
323 PO-205 POTENTIAL BENEFIT OF ADAPTIVE TREATMENT PLANNING FOR PDR PROSTATE BRACHYTHERAPY Dinkla, A.M.
 2012
 103 S2 p. S83-
1 p.
 artikel
324 PO-178 PREDICTION OF ERECTILE DYSFUNCTION FOLLOWING PROSTATE BRACHYTHERAPY: A DOSE VOLUME ANALYSIS OF PENILE STRUCTURES Beaufort, C.
 2012
 103 S2 p. S72-S73
2 p.
 artikel
325 PO-381 PREDICTIVE MODEL OF COMPLICATIONS AFTER PERIOPERATIVE HIGH DOSE RATE BRACHYTHERAPY San Miguel, I.
 2012
 103 S2 p. S152-
1 p.
 artikel
326 PO-191 PREDICTORS OF DISTANT METASTASIS AFTER EXTERNAL BEAM RADIATION AND HDR BRACHYTHERAPY BOOST FOR PROSTATE CANCER Lorentz, W.C.
 2012
 103 S2 p. S77-
1 p.
 artikel
327 PO-280 PRELIMINARY INVESTIGATION OF DOSE SUM OF PELVIC TOMOTHERAPY AND HDR BRACHYTHERAPY TREATMENT FOR CERVICAL CANCER Garelli, S.
 2012
 103 S2 p. S112-
1 p.
 artikel
328 PO-314 PRESCRIPTION DOSE EVALUATION FOR APBI WITH NON-INVASIVE BREAST BRACHYTHERAPY USING EQUIVALENT UNIFORM DOSE Leonard, K.L.
 2012
 103 S2 p. S125-S126
2 p.
 artikel
329 PO-374 PROSPECTIVE DOSE-ESCALADE STUDY OF ADJUVANT HIGH-DOSE-RATE BRACHYTHERAPY FOR SOFT TISSUE SARCOMAS Kacso, G.
 2012
 103 S2 p. S150-
1 p.
 artikel
330 PO-228 PROSPECTIVE EVALUATION OF PHARMACOLOGIC PENILE REHABILITATION FOLLOWING PROSTATE BRACHYTHERAPY Pugh, T.J.
 2012
 103 S2 p. S91-S92
2 p.
 artikel
331 PO-153 PROSPECTIVE MULTI-CENTRE DOSIMETRY STUDY OF I125 PROSTATE BRACHYTHERAPY PERFORMED AFTER TURP Salembier, C.
 2012
 103 S2 p. S63-S64
2 p.
 artikel
332 PO-211 PROSTATE BRACHYTHERAPY USING AN AUTOMATIC SEED AFTERLOADER: PRELIMINARY EXPERIENCE IN 1037 PATIENTS Pommier, P.
 2012
 103 S2 p. S85-
1 p.
 artikel
333 PO-192 PROSTATE CANCER BOOST USING HDR BRACHYTHERAPY: EARLY TOXICITY ANALYSIS OF 3 DIFFERENT FRACTIONATION SCHEMES Chand-Fouché, M.E.
 2012
 103 S2 p. S77-S78
2 p.
 artikel
334 PO-183 PROSTATE CANCER BOOST USING HDR BRACHYTHERAPY: LEARNING CURVE ANALYSIS AFTER 103 CONSECUTIVE PATIENTS Hijazi, H.
 2012
 103 S2 p. S74-S75
2 p.
 artikel
335 PO-188 PROSTATE HDR BRACHYTHERAPY CATHETER DISPLACEMENT BETWEEN PLANNING AND TREATMENT DELIVERY AT SYDNEY CANCER CENTRE Whitaker, M.
 2012
 103 S2 p. S76-
1 p.
 artikel
336 PO-199 PROSTATE VOLUME-BASED NOMOGRAMS FOR PROSTATE SEED IMPLANTS: CUSTOMIZING FOR A RANGE OF SEED ACTIVITIES Gardner, S.J.
 2012
 103 S2 p. S80-S81
2 p.
 artikel
337 PO-163 PSA RESPONSE TO TRI-MODALITY PREDICTS BIOCHEMICAL PROGRESSION FREE SURVIVAL IN LOCALIZED PROSTATE CANCER Aoki, M.
 2012
 103 S2 p. S67-
1 p.
 artikel
338 PO-362 QUALITY ASSURANCE OF TREATMENT PLANS IN HDR/PDR BRACHYTHERAPY. A METHOD OF VERIFYING CALCULATED TREATMENT TIMES With, A.
 2012
 103 S2 p. S146-
1 p.
 artikel
339 PO-208 QUALITY OF HDR BRACHYTHERAPY OF FAVORABLE LOCALIZED PROSTATE CANCER AND NUMBER OF IMPLANTED NEEDLES Slobina, E.
 2012
 103 S2 p. S84-
1 p.
 artikel
340 PO-351 RADIATION SAFETY: SOURCE POSITION INDICATOR AS A QUALITY ASSURANCE TOOL IN HIGH DOSE RATE (HDR) BRACHYTHERAPY Oyekunle, E.O.
 2012
 103 S2 p. S141-S142
2 p.
 artikel
341 PO-398 RADIOACTIVITY SEEDS INTERSTITIAL BRACHYTHERAPY TREATING MALIGNANT SALIVARY GLAND TUMORS Zhang, J.
 2012
 103 S2 p. S158-
1 p.
 artikel
342 PO-378 RADIOBIOLOGICAL ASSESSMENT OF TREATMENT DURATION AND RADIONUCLIDE CHOICE FOR COMS EYE PLAQUE BRACHYTHERAPY Gagne, N.L.
 2012
 103 S2 p. S151-
1 p.
 artikel
343 PO-282 RADIOCHEMOTHERAPY AND HDR BOOST IN CERVICAL CANCER: ANALYSIS ON TOXICITY, A 10 YEARS SINGLE INSITUTION EXPERIENCE Colombo, A.
 2012
 103 S2 p. S113-
1 p.
 artikel
344 PO-279 RADIOTHERAPY AND MULTIMODALITY TREATMENT FOR PATIENTS WITH LOCALLY ADVANCED UTERINE CERVIX CANCER Litvinova, T.
 2012
 103 S2 p. S112-
1 p.
 artikel
345 PO-276 REAL-TIME DOSIMETRIC QUALITY ASSURANCE FOR HIGH-DOSE-RATE GYNECOLOGICAL BRACHYTHERAPY Richardson, S.
 2012
 103 S2 p. S111-
1 p.
 artikel
346 PO-214 REAL-TIME INTRAOPERATIVE BRACHYTHERAPY PLANNING WITH I-125 SEEDS REDUCES THE ACUTE AND SUBACUTE TOXICITY Chicata Sutmoller, V.
 2012
 103 S2 p. S86-
1 p.
 artikel
347 PO-157 RECTAL BALLOONS AND THE RISK OF SECONDARY RECTAL CANCER AFTER COMBINED MODALITY PROSTATE RADIATION Burri, R.J.
 2012
 103 S2 p. S65-
1 p.
 artikel
348 PO-207 RECTAL BLEEDING IN PATIENTS TREATED WITH HDR BRACHYTHERAPY COMBINED WITH EBRT FOR PROSTATE CANCER Kariya, S.
 2012
 103 S2 p. S83-S84
2 p.
 artikel
349 PO-203 RECTUM PRESERVATION BY BOLUS HYALURONAN INJECTION INTO PERI/PARA RECTAL SPACE DURING HDR-BT OF PROSTATE CANCER Kishi, K.
 2012
 103 S2 p. S82-
1 p.
 artikel
350 PO-259 REEXAMINING ABS RECOMMENDATIONS FOR HDR VAGINAL BRACHYTHERAPY FOR UPSC OR CLEAR CELL ENDOMETRIAL CANCER Yondorf, M.
 2012
 103 S2 p. S104-S105
2 p.
 artikel
351 PO-209 RESCUE TREATMENT IN PROSTATE CANCER FOR LOCAL RELAPSE AFTER RADIOTHERAPY WITH HIGH-DOSE RATE BRACHYTHERAPY Quispe Santibáñez, K.
 2012
 103 S2 p. S84-S85
2 p.
 artikel
352 PO-307 RESULTS OF CT BASED BRACHYTHERAPY PLANNING FOR IIB-IVA CERVICAL CANCER PATIENTS Garipagaoglu, M.
 2012
 103 S2 p. S123-
1 p.
 artikel
353 PO-290 RESULTS OF THE HYBRID INTERSTITIAL-INTRACAVITARY UTRECHT APPLICATOR FOR CERVICAL CANCER IN AN OUTPATIENT SETTING Bernstein, M.
 2012
 103 S2 p. S116-
1 p.
 artikel
354 PO-376 ROLE OF INTRALUMINAL BRACHYTHERAPY IN LOCALLY ADVANCED CARCINOMA ESOPHAGUS Behera, M.K.
 2012
 103 S2 p. S150-
1 p.
 artikel
355 PO-147 SECTOR ANALYSIS OF I-125 PROSTATE IMPLANTS PROVIDES AN EFFECTIVE METHOD IN COMPARING PRE AND POST-IMPLANT DOSIMETRY Mohamed Yoosuf, A.B.
 2012
 103 S2 p. S61-
1 p.
 artikel
356 PO-164 SEED MIGRATION IN PROSTATE BRACHYTHERAPY DEPENDS ON EXPERIENCE AND TECHNIQUE Delouya, G.
 2012
 103 S2 p. S67-
1 p.
 artikel
357 PO-331 SIMPLE PHANTOM SETUP FOR ULTRASOUND GUIDED PROSTATE HDR BRACHYTHERAPY QUALITY ASSURANCE PROCEDURE Ribeiro Nuno Ramos, T.
 2012
 103 S2 p. S131-S132
2 p.
 artikel
358 PO-320 SINGLE FRACTION (7 GY) OF HDR-BRACHYTHERAPY AS BOOST IN BREAST-CONSERVING THERAPY: 5 YEARS RESULTS IN 139 PATIENTS Taboada Valladares, B.
 2012
 103 S2 p. S127-S128
2 p.
 artikel
359 PO-230 SINGLE FRACTION HDR BRACHYTHERAPY AND EBRT FOR PROSTATE CANCER: AN ANALYSIS OF HEALTH RELATED QUALITY OF LIFE Malik, J.
 2012
 103 S2 p. S92-S93
2 p.
 artikel
360 PO-318 SINGLE-LUMEN APBIB AT THE JOHN THEURER CANCER CENTER: CONSENSUS GUIDLINE CONFORMANCE AND OUTCOMES Godfrey, L.
 2012
 103 S2 p. S127-
1 p.
 artikel
361 PO-301 SOURCE POSITION LOCALIZATION FOR ICBT TANDEM & OVOID APPLICATORS UTILIZING ONCENTRA BRACHY APPLICATOR MODELING Kemp, J.
 2012
 103 S2 p. S120-
1 p.
 artikel
362 PO-247 STUDY OF MR IMAGE BASED INTERSTITIAL BRACHYTHERAPY USING THERMOPLASTIC CATHETER FOR ADVANCED CERVICAL CANCER Palled, S.
 2012
 103 S2 p. S99-S100
2 p.
 artikel
363 PO-385 SUBLOBAR RESECTION AND BRACHYTHERAPY FOR NON SMALL CELL LUNG CANCER IN PATIENTS WITH HISTORY OF PRIOR MALIGNANCY Jain, A.
 2012
 103 S2 p. S153-S154
2 p.
 artikel
364 PO-359 SYSTEM FOR FABRICATION OF CUSTOM BRACHYTHERAPY-SPECIFIC PROSTATE PHANTOMS Zhang, N.
 2012
 103 S2 p. S144-S145
2 p.
 artikel
365 PO-380 THE “CLAWS”: A GOLD APPLICATOR LOADED WITH I-125 SEEDS FOR LOCALIZED WHOLE EYE RADIOTHERAPY Trauernicht, C.J.
 2012
 103 S2 p. S151-S152
2 p.
 artikel
366 PO-400 THE CLINICAL APPLICATIONS OF SURFACE HDR LEIPZIG APPLICATORS Ozbay, I.
 2012
 103 S2 p. S159-
1 p.
 artikel
367 PO-375 THE CLINICAL VALUE AND SAFETY OF TRANS-SUPERIOR VENA CAVA BRACHYTHERAPY FOR METASTATIC MEDIASTINAL LYMPH NODES Li, Y.
 2012
 103 S2 p. S150-
1 p.
 artikel
368 PO-367 THE DIFFERENT BIOLOGICAL EFFECTS OF SINGLE, FRACTIONED AND CLDR IRRADIATION IN CL187 COLORECTAL CANCER CELLS Wang, H.
 2012
 103 S2 p. S148-
1 p.
 artikel
369 PO-281 THE EFFECT OF BODY MASS INDEX ON MAXIMUM RECTAL DOSE IN HIGH DOSE RATE BRACHYTHERAPY FOR CERVICAL CANCER Lim, J.
 2012
 103 S2 p. S112-
1 p.
 artikel
370 PO-190 THE EFFICACY OF A1 BLOCKERS FOR ACUTE URINARY SYMPTOMS AFTER IODINE-125 PROSTATE BRACHYTHERAPY Tadahiko, K.
 2012
 103 S2 p. S77-
1 p.
 artikel
371 PO-150 THE IMPACT OF GEOMETRIC INACCURACIES ON RESULTING DOSE DISTRIBUTION DURING HDR PROSTATE BRACHY-THERAPY Paluska, P.
 2012
 103 S2 p. S62-S63
2 p.
 artikel
372 PO-239 THE ROLE OF VAGINAL BRACHYTHERAPY IN THE TREATMENT OF STAGE I PAPILLARY SEROUS OR CLEAR CELL ENDOMETRIAL CANCER Barney, B.
 2012
 103 S2 p. S97-
1 p.
 artikel
373 PO-241 THREE-DIMENSIONAL IMAGE GUIDED PULSED DOSE RATE BRACHYTHERAPY BOOSTING BULKY CERVICAL CANCER Refaat, T.
 2012
 103 S2 p. S97-S98
2 p.
 artikel
374 PO-179 THREE YEAR RESULTS OF HDR-BRACHYTHERAPY FOR PROSTATE CANCER TREATED WITH NEW REGIMEN OF 45.5 GY IN SEVEN FRACTIONS Konishi, K.
 2012
 103 S2 p. S73-
1 p.
 artikel
375 PO-410 TRANSLATIONAL NEOADJUVANT HIGH DOSE RATE ENDORECTAL BRACHYTHERAPY FOR RECTAL ADENOCARCINOMA Herman, J.
 2012
 103 S2 p. S163-
1 p.
 artikel
376 PO-271 TRANSRECTAL ULTRASOUND FOR THE ASSESSMENT OF CERVIX CANCER IN THE COURSE OF PRIMARY RADIOCH EMOTHERAPY Schmid, M.
 2012
 103 S2 p. S109-
1 p.
 artikel
377 PO-185 TWO HDR BRACHYTHERAPY SCHEDULES AS MONOTHERAPY IN PROSTATE CANCER: ANALYSIS OF TOXICITY IN 178 PATIENTS Colombo, A.
 2012
 103 S2 p. S75-
1 p.
 artikel
378 PO-194 ULTRASOUND-CT FUSION COMPARED TO MR-CT FUSION FOR POST IMPLANT DOSIMETRY IN PERMANENT PROSTATE BRACHYTHERAPY Crook, J.M.
 2012
 103 S2 p. S78-
1 p.
 artikel
379 PO-368 ULTRASOUND-GUIDED PERCUTANEOUS IODINE-125 SEED IMPLANTATION FOR TREATING LIVER MALIGNANCIES Ttian, S.Q.
 2012
 103 S2 p. S148-
1 p.
 artikel
380 PO-181 URETHRA CONSTRAINT ON 160 GY EXCLUSIVE PROSTATE PERMANENT BRACHYTHERAPY Richart Sancho, J.
 2012
 103 S2 p. S73-S74
2 p.
 artikel
381 PO-210 URINARY ENGRAILED-2: A NOVEL BIOMARKER FOR FOLLOW UP POST RADICAL TREATMENT FOR PROSTATE CANCER Javed, S.
 2012
 103 S2 p. S85-
1 p.
 artikel
382 PO-156 URINARY MORBIDITY RELATED TO PROSTATE BRACHYTHERAPY WITH OR WITHOUT EXTERNAL BEAM RADIATION THERAPY Ishida, M.
 2012
 103 S2 p. S64-S65
2 p.
 artikel
383 PO-272 USING HDR BRACHYTHERAPY DOSE DISTRIBUTIONS TO SHAPE PARAMETRIAL BOOST FIELDS Chapman, K.L.
 2012
 103 S2 p. S109-
1 p.
 artikel
384 PO-261 UTERINE PERFORATION DURING INTRACAVITARY BRACHYTHERAPY FOR GYNECOLOGICAL MALIGNANCIES Segedin, B.
 2012
 103 S2 p. S105-
1 p.
 artikel
385 PO-291 UTRECHT INTERSTITIAL CT/MRI APPLICATOR FOR MRI IMAGING GUIDED HDR-BRACHYTHERAPY: DOSE VOLUME ANALYSIS Celada, F.
 2012
 103 S2 p. S116-
1 p.
 artikel
386 PO-338 VAGINAL CUFF BRACHYTHERAPY USING OVOIDS: COMPARISON OF POINT BASED AND TARGET BASED PRESCRIPTION Sharma, S.
 2012
 103 S2 p. S136-
1 p.
 artikel
387 PO-253 VAGINAL VAULT HDR BRACHYTHERAPY AS SOLE ADJUVANT THERAPY FOR ENDOMETRIAL CANCER Stillie, A.
 2012
 103 S2 p. S102-
1 p.
 artikel
388 PO-168 VALIDITY OF INTRAOPERATIVE INTERACTIVE PLANNING TECHNIQUE BASED ON ANATOMIC DISTRIBUTION OF PROSTATE CANCER Keisei, O.
 2012
 103 S2 p. S69-
1 p.
 artikel
389 PO-287 VOLUME RELATED HR-CTV COVERAGE USING MRI BASED OPTIMISED TREATMENT PLANS FOR HDR BRACHYTHERAPY CERVIX TREATMENTS Aldridge, S.
 2012
 103 S2 p. S114-S115
2 p.
 artikel
390 PO-404 VOXELIZED DOSE-RESPONSE STUDY IN HIGH DOSE RATE (HDR) 192IR BRACHYTHERAPY FOR RECTAL CANCER Hobbs, R.F.
 2012
 103 S2 p. S161-
1 p.
 artikel
391 PO-200 V150 PREDICTS ERECTILE OUTCOME IN PATIENTS UNDERGOING LOW-DOSE-RATE (LDR) BRACHYTHERAPY ALONE FOR PROSTATE CANCER Kollmeier, M.A.
 2012
 103 S2 p. S81-
1 p.
 artikel
392 PO-223 12 YEARS OF EXPERIENCE IN PERMANENT IMPLANTATION OF THE PROSTATE WITH PD-103 AND I- 125 SEEDS Oismueller, R.
 2012
 103 S2 p. S89-S90
2 p.
 artikel
393 15 PRIMARY FOCAL THERAPY OF PROSTATE CANCER: ROLE OF DIAGNOSTIC IMAGING Coakley, F.V.
 2012
 103 S2 p. S6-
1 p.
 artikel
394 80 RADICAL SALVAGE PROSTATECTOMY FOR RADIORECURRENT PROSTATE CANCER Heidenreich, A.
 2012
 103 S2 p. S32-S33
2 p.
 artikel
395 50 RADIOBIOLOGICAL CHANGES DURING THE COURSE OF TREATMENT Williams, S.
 2012
 103 S2 p. S21-
1 p.
 artikel
396 100 RADIOLOGICAL INTERVENTION Gademann, G.
 2012
 103 S2 p. S39-
1 p.
 artikel
397 20 RAMIFICATIONS OF DOSE-RATE TO WATER CALIBRATIONS ON CLINICAL DOSIMETRY FOR PHOTON-EMITTING BRACHYTHERAPY SOURCES Rivard, M.J.
 2012
 103 S2 p. S8-
1 p.
 artikel
398 48 REPAIR HALF-TIME Bentzen, S.
 2012
 103 S2 p. S20-
1 p.
 artikel
399 137 REPEAT BREAST CONSERVATION THERAPY: USA EXPERIENCE Patel, R.
 2012
 103 S2 p. S56-
1 p.
 artikel
400 99 RIGID RECTOSCOPY TO IMPROVE RADIATION TARGETING AND INDIVIDUALISE MANAGEMENT OF RECTAL CANCER Gérard, J.P.
 2012
 103 S2 p. S39-
1 p.
 artikel
401 98 ROBOT ASSISTED MESH BRACHYTHERAPY AFTER SUBLOBAR RESECTION FOR EARLY STAGE LUNG CANCER Khuntia, D.
 2012
 103 S2 p. S39-
1 p.
 artikel
402 2 ROLE OF FUNCTIONAL IMAGING Carey, B.
 2012
 103 S2 p. S1-
1 p.
 artikel
403 138 SECOND CONSERVATIVE TREATMENT FOR IPSILATERAL BREAST CANCER RECURRENCE: GEC-ESTRO BREAST WG STUDY Hannoun-Levi, J.
 2012
 103 S2 p. S56-
1 p.
 artikel
404 105 SKIN BRACHYTHERAPY FROM THE DERMATOLOGIST SIDE Strasswimmer, J.
 2012
 103 S2 p. S41-
1 p.
 artikel
405 63 SOUTH AMERICA de la Torre, M.
 2012
 103 S2 p. S24-
1 p.
 artikel
406 97 STRATEGIES TO PREVENT ERRORS IN BRACHYTHERAPY: LEARNING FROM OUR MISTAKES Lee, R.
 2012
 103 S2 p. S38-
1 p.
 artikel
407 94 SYSTEMATIC OVERVIEW AND REPORTING GUIDELINES FOR UNCERTAINTIES IN CLINICAL BRACHYTHERAPY Kirisits, C.
 2012
 103 S2 p. S38-
1 p.
 artikel
408 9 TARGIT Joseph, D.J.
 2012
 103 S2 p. S4-
1 p.
 artikel
409 16 TECHNICAL POSSIBILITIES OF RADIOTHERAPY IN PRIMARY FOCAL THERAPY OF PROSTATE CANCER Kovács, G.
 2012
 103 S2 p. S6-S7
2 p.
 artikel
410 93 TG-138 REPORT: UNCERTAINTIES IN PHOTON EMITTING BRACHYTHERAPY SOURCE DOSIMETRY Thomadsen, B.
 2012
 103 S2 p. S38-
1 p.
 artikel
411 118 THE ADVANTAGES AND CRITICALITIES OF NEW DOSE CALCULATION ALGORITHMS: WHEN PRESCRIPTION DOSES SHOULD CHANGE? Guinot, J.L.
 2012
 103 S2 p. S47-S48
2 p.
 artikel
412 64 THE ROLE OF INDUSTRY IN DEVELOPING COST-EFFECTIVE BRACHYTHERAPY Rosenblatt, E.
 2012
 103 S2 p. S24-
1 p.
 artikel
413 102 UICC: RADIATION THERAPY IN THE WORLD Gospodarowicz, M.
 2012
 103 S2 p. S40-
1 p.
 artikel
414 95 UNCERTAINTIES IN IMAGE GUIDED BRACHYTHERAPY: ECONOMICAL AND LOGISTICAL ASPECTS Polo Rubio, J.A.
 2012
 103 S2 p. S38-
1 p.
 artikel
415 14 UNDERSTANDING THE PATHOLOGICAL FEATURES OF PROSTATE CANCER AS A FOUNDATION FOR FOCAL TARGETED BT Bostwick, D.
 2012
 103 S2 p. S6-
1 p.
 artikel
416 109 UPCOMING ICRU/GEC ESTRO RECOMMENDATIONS FOR BRACHYTHERAPY IN CANCER OF THE CERVIX (2) Kirisits, C.
 2012
 103 S2 p. S42-S43
2 p.
 artikel
417 108 UPCOMING ICRU/GEC ESTRO RECOMMENDATIONS FOR BRACHYTHERAPY IN CANCER OF THE CERVIX (1) Potter, R.
 2012
 103 S2 p. S42-
1 p.
 artikel
418 130 VAGINAL BRACHYTHERAPY SHOULD BE THE STANDARD ADJUVANT TREATMENT Creutzberg, C.L.
 2012
 103 S2 p. S52-S53
2 p.
 artikel
419 103 WHAT ARE THE BEST INDICATIONS FOR BRACHYTHERAPY IN NON-MELANOMA SKIN CANCERS? Delannes, M.
 2012
 103 S2 p. S40-S41
2 p.
 artikel
420 23 WHAT ARE THE PITFALLS (INTEGRATING ORGAN MOTION, EXTERNAL BEAM) Erickson, B.
 2012
 103 S2 p. S9-
1 p.
 artikel
                             420 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland